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Abstract 
The aims of this dissertation were to provide innovative, applicable insights regarding the impact 
of single-meal consumption on metabolic and inflammatory responses in the acute post-meal 
(“postprandial”) period. In Chapter 2, the connection between large postprandial glucose and 
triglyceride (TG) fluxes and cardiovascular disease (CVD) risk were reviewed. A new marker of 
metabolic status, Metabolic Load Index (MLI), calculated by adding glucose and TG, was 
proposed based on several considerations: 1) independent associations between postprandial 
glucose and TG with CVD risk, although the substrates are considered to increase risk through 
similar mechanisms; 2) postprandial glucose and TG responses are interrelated; and 3) meals 
consumed in daily life typically contain both carbohydrate and fat. MLI may be useful in 
characterizing metabolic status/risk in both clinical and research settings. Chapter 3 was a 
systematic review with the purpose of objectively describing postprandial responses (i.e. 
magnitude and timing) to a high-fat meal (HFM) in five commonly assessed inflammatory 
markers: interleukin (IL)-6, C-reactive protein (CRP), tumor necrosis factor (TNF)-α, IL-1β, and 
IL-8. IL-6 increased in >70% of studies, starting at ~1.4 pg/mL pre-meal and peaking at ~2.9 
pg/mL ~6 hours post-HFM. Other markers (CRP, TNF-α, IL-1β, and IL-8) did not change after 
the HFM in the majority of studies. These findings suggest that IL-6 is an inflammatory marker 
that routinely increases following HFM consumption. Future postprandial studies should further 
investigate IL-6, as well as explore novel markers of inflammation. In Chapter 4, we compared 
the metabolic and inflammatory responses to a HFM (17 kcal/kg, 60% fat), representative of 
meals used in previous postprandial studies, to two meal trials that were more reflective of 
typical eating patterns: a moderate-fat meal (MFM; 8.5 kcal/kg, 30% fat), and a biphasic meal 
(BPM), in which the MFM was consumed twice, three hours apart. The HFM elicited a greater 
  
total area-under-the-curve (tAUC) TG response (1348.8 ± 783.7 mg/dL x 6 hrs) compared to the 
MFM (765.8 ± 486.8 mg/dL x 6 hrs; p = 0.0005) and the BPM (951.8 ± 787.7 mg/dL x 6 hrs; p = 
0.03), but the MFM and BPM were not different (p = 0.72). It appears that the large postprandial 
TG response observed in previous studies may not be representative of the daily metabolic 
challenge for many individuals. Chapter 5 assessed the impact of both aging and chronic 
physical activity level on postprandial metabolic responses by comparing three groups: younger 
active (YA), older active (OA), and older inactive (OI) adults. The TG tAUC response was lower 
in YA (407.9 ± 115.1 mg/dL x 6 hr) compared to OA (625.6 ± 169.0 mg/dL x 6 hr; p = 0.02) and 
OI (961.2 ± 363.6 mg/dL x 6 hr; p = 0.0002), while the OA group TG tAUC was lower than OI 
(p = 0.02). Thus, it is likely that both aging and chronic physical activity level impact the 
postprandial metabolic response. This series of projects provides needed clarification regarding 
the postprandial metabolic and inflammatory responses to single-meal intake, particularly in the 
context of real-life application.  
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MFM (765.8 ± 486.8 mg/dL x 6 hrs; p = 0.0005) and the BPM (951.8 ± 787.7 mg/dL x 6 hrs; p = 
0.03), but the MFM and BPM were not different (p = 0.72). It appears that the large postprandial 
TG response observed in previous studies may not be representative of the daily metabolic 
challenge for many individuals. Chapter 5 assessed the impact of both aging and chronic 
physical activity level on postprandial metabolic responses by comparing three groups: younger 
active (YA), older active (OA), and older inactive (OI) adults. The TG tAUC response was lower 
in YA (407.9 ± 115.1 mg/dL x 6 hr) compared to OA (625.6 ± 169.0 mg/dL x 6 hr; p = 0.02) and 
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postprandial metabolic response. This series of projects provides needed clarification regarding 
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Chapter 1 - Introduction 
 Rationale for Postprandial Assessment 
Dietary intake has been well-established as a lifestyle factor that can modify health status (1). 
Diets high in saturated fat, refined carbohydrates, red meat, and processed foods; and low in 
fiber, fruits, vegetables, nuts, and legumes are considered to increase risk for certain chronic 
diseases, such as cardiovascular disease (CVD) and cancer (1). Additionally, there is evidence 
that consumption of single meals can modify health status via physiological responses occurring 
in the human body in the transient period following meal consumption (2,3). Indeed, the 
following outcomes associated with CVD risk have been shown to occur in the acute hours after 
a single high-fat meal (HFM): increased inflammation (4), impaired endothelial function (5), 
elevated low-grade endotoxemia (6), increased adhesion molecules (7), and elevated blood 
coagulation/thrombotic factors (8,9,10). Findings suggest a strong positive association between 
the magnitude and duration of the post-meal (postprandial) response with risk for cardiovascular 
events (11). Based on data for typical eating patterns of individuals in Western society, it is 
likely that most individuals spend the majority of their day in a “postprandial state” (12), which 
can be considered the acute period following meal consumption in which substrate clearance 
mechanisms are active, attempting to return metabolic levels to baseline/homeostasis. Thus, 
assessing the features of the postprandial response to single-meal consumption is crucial to 
understanding the metabolic state of individuals in daily living. 
 Triglycerides in the Postprandial Period 
Triglycerides (TG) are a type of lipid composed of a glycerol backbone and three fatty acids. 
Due to their hydrophobic nature, TG circulate in the blood within lipoproteins, primarily 
chylomicrons, very-low-density lipoprotein cholesterol (VLDL-C) and low-density lipoprotein 
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cholesterol (LDL-C). Many studies have confirmed that TG increase in the postprandial period 
following a HFM, typically peaking approximately four hours after the meal and returning to 
baseline around eight hours post-HFM (11,13). There is a general methodology for assessing the 
postprandial TG response (“postprandial lipemia”). An individual will 1) fast for 10-12 hours 
prior to their appointment; 2) have a baseline/fasting blood draw conducted; 3) eat a HFM; and 
4) remain in the lab for 6-8 hours (without eating) while blood samples are drawn periodically to 
characterize the postprandial TG response. Clinical studies have revealed that prolonged and/or 
large increases in magnitude in TG following a HFM are associated with increased risk for CVD. 
(11). In addition, while it is equivocal whether fasting TG levels are a strong predictor of CVD 
risk (2), the preponderance of evidence points to postprandial/non-fasting TG as a strong 
independent predictor of CVD risk (14). 
 Glucose in the Postprandial Period 
Glucose is also a metabolic substrate that increases in circulation following meal consumption, 
as long as the meal contains sufficient carbohydrate. However, glucose fluxes occur more rapidly 
as compared to TG, generally peaking and returning to near baseline within two hours in healthy 
individuals following a glucose challenge (15). Evidence suggests that a large postprandial 
glucose response is associated with both CVD (16) and type 2 diabetes (17). Similarly to TG, it 
appears that postprandial glycemia is a better predictor of chronic disease risk than fasting 
glucose values (16). There is even evidence indicating that >30% of people diagnosed with type 
2 diabetes, determined via postprandial glucose challenge, present with normal fasting glucose 
levels (18). Clearly, with regard to both TG and glucose, there is considerable merit to 
assessment of postprandial metabolic responses to a single meal or challenge, as postprandial 
values better predict risk as compared to fasting values. 
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 Inflammatory Markers in the Postprandial Period 
Deleterious physiological changes in the postprandial period are not limited to circulating energy 
available in the form of TG and glucose. Inflammation is thought to be involved in the 
development of several chronic diseases, including CVD (19). In the past decade, many studies 
have tested markers of inflammation pre- and post-HFM (20). Inflammatory markers, such as C-
reactive protein (CRP), tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-1β, and IL-8, have 
been shown to be positively associated with CVD risk (21- 25). While there are numerous 
markers of inflammation, each with slightly different physiological functioning, many exert their 
detrimental effects via participating in, and further propagating, the inflammatory cascade that is 
a hallmark of the atherosclerotic lesion process (19). Thus, testing the postprandial responses of 
pro-inflammatory cytokines and other molecules has the potential to further our understanding of 
the connection between dietary intake and chronic disease risk. Several previous studies have 
reported increases in commonly-assessed markers of inflammation in the postprandial period 
following HFM consumption, including CRP, TNF-α, IL-6, and IL-1β (26). The inflammatory 
response, in addition to lipemic and glycemic responses, points to the potential deleterious 
physiological outcomes that can occur in response to intake of a single HFM. 
 Gaps in Current Knowledge 
Several issues and questions remain unaddressed in understanding the relationship between 
single-meal intake and the acute metabolic and inflammatory responses that are linked to chronic 
disease risk. First, while large TG and glucose fluxes have been shown to be independently 
associated with elevated chronic disease risk, and these substrates increase risk through similar 
physiological mechanisms, no effort has been made to include TG and glucose in a single 
metabolic index representative of the total metabolic challenge (energy availability) faced by the 
4 
 
body. This is problematic, since it has been revealed that addition of carbohydrate to a HFM can 
blunt the postprandial lipemic response (27), and addition of fat to a high-carbohydrate meal can 
blunt the glycemic response (28). Thus, the postprandial responses of glucose and TG are 
interdependent. Additionally, meals consumed in daily living typically contain a mixed 
macronutrient distribution. Based on these reasons, it may be valuable to develop a 
comprehensive index of metabolic challenge in the postprandial period that considers both TG 
and glucose. Second, postprandial inflammation has been assessed in many studies, but there is 
no consensus with regard to how the most commonly assessed markers respond, in terms of 
magnitude and timing, to a HFM. From both clinical and research perspectives, it would be 
valuable to synthesize the results of previous investigations in order to determine which markers 
of inflammation are the most likely to respond, and the characteristics of those responses, 
following the consumption of a HFM. Next, a common issue with many previous studies 
investigating postprandial responses has been the utilization of test meal protocols that are not 
realistic or “true-to-life”. For instance, it is not uncommon for participants to eat a very large 
meal (e.g., ~1500 kcal, 60% fat), then not eat again for 6-8 hours while their response is 
monitored (29). Some studies will also simply use a laboratory-derived liquid test meal, rather 
than mixed meals (30). These study design features weaken the practical applicability of the 
findings from postprandial investigations. Studies investigating the postprandial metabolic and 
inflammatory responses to realistic meal challenges are warranted. Finally, older adults have 
been sparsely tested in the postprandial literature. As older adults are at increased risk for CVD 
(31), as well as a growing segment of the population (32), more research focusing on the 
postprandial response in older adults, including the lifestyle factors that may affect the response, 
would be very useful. Overall, given the connection between the postprandial response and CVD 
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risk, this dissertation aimed to fill some of the gaps in knowledge regarding postprandial 
responses to single-meals in hopes of furthering our understanding of this important lifestyle 
factor. 
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Chapter 2 - Summation of Blood Glucose and Triglycerides to 
Characterise the “Metabolic Load Index” 
 Abstract 
Research points to postprandial glucose and triglyceride measures as preferable assessments of 
cardiovascular risk as compared to fasting values. Although elevated postprandial glycemic and 
lipemic responses are thought to substantially increase chronic disease risk, postprandial 
glycemia and lipemia have historically only been considered separately. However, carbohydrates 
and fats can generally “compete” for clearance from the stomach, small intestine, bloodstream, 
and within the peripheral cell. Further, there are previous data demonstrating that the addition of 
carbohydrate to a high-fat meal blunts the postprandial lipemic response and the addition of fat 
to a high-carbohydrate meal blunts the postprandial glycemic response. Thus, postprandial 
glycemia and lipemia are interrelated. The purpose of this brief review is twofold: first, to review 
the current evidence implicating postprandial glycemia and lipemia in chronic disease risk, and 
second, to examine the possible utility of a single postprandial glycemic and lipemic summative 
value, which will be referred to as the metabolic load index. The potential benefits of the 
metabolic load index extend to the clinician, patient, and researcher. 
 Introduction 
Meal consumption, particularly meals that are high in fat, processed sugars, and total calories, 
results in transient elevations in blood glucose and lipids. These elevations, termed postprandial 
glycemia and lipemia, respectively, have both been linked to the progression of cardiovascular 
disease (CVD), primarily through a resultant rise in oxidative stress, inflammation, and 
endothelial dysfunction (1,2). Thus, exaggerated postprandial glycemia and lipemia, if 
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experienced several times per day, represent a clear metabolic challenge to homeostasis. 
Individuals in Western society are thought to spend most of their waking hours in the 
postprandial state (3), and thus in a near-constant state of postprandial challenge which could be 
amplified to prolonged dysmetabolism in the case of individuals at risk for metabolic disease. 
Hence, recent research has been devoted to better understand how the body, in health as well as 
disease, handles these metabolic excursions. Typically postprandial glycemic and lipemic 
responses are characterized by measuring blood glucose and triglycerides serially for a given 
amount of time after a meal, and from these data, calculating area under the curve (AUC). While 
these methods are effective in characterizing the glycemic and lipemic responses independently, 
previous efforts have not considered them simultaneously. However, meals typically contain 
both carbohydrate and fat, as well as some protein; thus it may be worthwhile to consider the 
summative metabolic response of both carbohydrate and lipids, as opposed to simply focusing on 
just one or the other. This brief review will first consider postprandial glycemia and lipemia 
independently in relation to metabolic status and CVD risk, followed by a discussion of the 
potential utility of a postprandial metabolic load index that combines glycemia and lipemia 
together, indicating total circulating energy availability. 
 Blood Glucose and Metabolic Status/Risk 
Fasting Blood Glucose, HbA1c, and Cardiovascular Risk 
Assessment of long-term glucose control via hemoglobin A1c (HbA1c) or fasting glucose levels 
are commonly used as valuations of cardiovascular and diabetic risk (4). This practice is based 
on several epidemiological studies linking HbA1c levels or impaired fasting glucose to heart or 
vascular disease.(5,6) For example, the United Kingdom Prospective Diabetes Study found that 
mean HbA1c over time in the cohort was a valuable predictor of ischemic heart disease (5). 
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Specifically, the data showed that for every 1% increase in HbA1c there was a ~10% increase in 
heart disease risk (5). With regard to fasting glucose levels, a meta-analysis of nearly 700,000 
people found that fasting blood glucose was modestly and non-linearly associated with vascular 
disease in diabetic individuals (6). Finally, an epidemiological study in US adolescents also 
found a link between impaired fasting glucose and CVD risk factors, including high fasting 
insulin, total and low-density lipoprotein (LDL) cholesterol, triglycerides, systolic blood 
pressure, and low high-density lipoprotein (HDL) cholesterol (7). Thus, fasting glucose and 
HbA1c measures are considered by some to be valuable screening tools for type 2 diabetes and 
indeed are commonly used in clinical environments. However, it is interesting to note that early 
in the development of type 2 diabetes, postprandial glucose tolerance plays a large role, whereas 
fasting glucose plays a more substantial role later in the disease process (8). In other words, 
derangements in fasting blood glucose take longer to develop, whereas impairments in post-
challenge glucose tolerance could be observed earlier. 
Post-challenge/postprandial Blood Glucose and Cardiovascular Risk: 
Epidemiological Studies 
In contrast to impaired fasting glucose, there are substantial data suggesting impaired glucose 
tolerance should be preferentially considered when assessing chronic disease risk (9,10). To 
support this, Tominaga et al. (9) found that survival rates in frank diabetes and impaired glucose 
tolerance were significantly lower than individuals with impaired fasting glucose, and further 
concluded that impaired glucose tolerance was a risk factor for CVD, but impaired fasting 
glucose was not. This finding was also supported by Blake et al. (10) who followed 937 
nondiabetic individuals for nearly ten years and found that impaired glucose tolerance was 
phenotypically different from impaired fasting glucose, and is associated with increased presence 
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of CVD risk factors. Further, the authors reported that individuals with impaired fasting glucose 
had CVD risk factors that were similar to individuals with normal glucose tolerance, further 
weakening the apparent utility of fasting glucose as a measure of CVD risk (10). 
A common way to assess glucose tolerance is the oral glucose tolerance test (OGTT), in which a 
plasma glucose measurement is made 2 hours after the ingestion of a standard glucose load, 
typically 75 or 100 g (11). There are numerous studies linking 2-hour glucose levels following an 
OGTT with CVD risk (12,13,14). The Chicago Heart Study found that 2-hour post-challenge 
glucose predicted all-cause mortality in a cohort of 11,554 white men and 666 black men (13). 
Similarly, results from the DECODE study indicated that high blood glucose following an OGTT 
was associated with increased risk of death, independent of fasting glucose (14). Finally, the 
Helsinki Policeman Study, Paris Prospective Study, and the Whitehall Study all found that all-
cause and coronary heart disease mortality was predicted by 2-hour post-challenge glucose 
following an OGTT (15,16,17,18).  
There are certainly drawbacks to the use of the OGTT to assess glucose tolerance and subsequent 
CVD risk. Consumption of 75-100 g of pure glucose rarely happens in daily life, and thus does 
not perfectly simulate the real-life glucose challenges faced daily by many people. Further, the 
extent of glycemia experienced following a meal is dependent on the entire contents of the test 
meal challenge. Hence, to better understand how the body tolerates glucose, it is important to 
challenge the metabolic system with a test meal that is representative of that experienced during 
daily living, such as a mixed meal. For this reason, some studies have utilized test meals that 
include fat and protein when assessing the glycemic response and subsequent CVD risk (19,20). 
Similar to studies using OGTTs, the Diabetes Intervention Study found that the postprandial 
glycemic response to a mixed meal was a significant predictor of coronary heart disease (19). 
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There is evidence that the glucose response seen following an OGTT is very similar to a mixed 
meal (in this case, consisting of wafers, canola oil, and honey), which suggests that the OGTT 
may have utility in assessing glucose tolerance, despite its apparent drawbacks (20). Thus, the 
glucose response to an OGTT may potentially be used as a proxy for, but is not identical to, true-
to-life postprandial glycemia (2). 
Post-challenge/postprandial Blood Glucose and Cardiovascular Risk: Intervention 
Studies 
An important intervention study connecting postprandial/post-challenge hyperglycemia to CVD 
risk is the STOP-NIDDM trial (21). Results from the STOP-NIDDM trial show that treatment of 
individuals with impaired glucose tolerance with acarbose, an α-glucosidase inhibitor that 
specifically reduces post-challenge glycemia, is associated with a substantial (36%) reduction in 
the likelihood of progressing to overt diabetes (21). Additionally, acarbose treatment was 
associated with a 34% risk reduction of developing hypertension and a 49% risk reduction for 
developing cardiovascular events (21). Finally, in a subgroup of participants in which carotid 
intima media thickness was measured, treatment with acarbose was associated with a 
significantly attenuated progression of intima media thickness compared to the control group 
(22). This work was subsequently supported by a meta-analysis that indicated a significant 
reduction in cardiovascular events following acarbose treatment in diabetic individuals, even 
after consideration of other risk factors (23).  
Another important intervention study by Esposito et al. (24) investigated the effects of two 
insulin secretagogues (compounds that promote insulin secretion) repaglinide and glyburide, 
which have differing effectiveness on hyperglycemia (with repaglinide being more effective), on 
surrogate measures of atherosclerosis. After one year, 52% of diabetic patients receiving 
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repaglinide and 18% of participants receiving glyburide displayed carotid intima media thickness 
regression (24). Further, C-reactive protein (CRP) and interleukin-6 (IL-6), both markers of 
systemic inflammation, decreased more in the repaglinide group than the glyburide group (24). 
These findings suggest a direct link between postprandial/post-challenge glucose intolerance and 
CVD. 
Mechanisms Behind Blood Glucose and Cardiovascular Risk 
How may post-challenge hyperglycemia and CVD be mechanistically linked? First and foremost, 
glucose intolerance is typically a feature of insulin resistance (25). Insulin resistance may result 
in deterioration of metabolic homeostasis in terms of both glucose and circulating free fatty acids 
(25). Not only do type 2 diabetes patients experience impaired clearance of glucose by insulin, 
they are also resistant to insulin-induced suppression of free fatty acid release (26). If not 
controlled, the elevated free fatty acid levels will precipitate elevated hepatic glucose production 
(27). The increased hepatic glucose production in combination with reduced insulin-stimulated 
glucose uptake produces a spike in blood glucose levels (25). The elevation of both fasting and 
postprandial glycemia results in numerous adverse outcomes. 
To start, diabetic individuals typically experience endothelial dysfunction early in the disease 
process (28). Specifically, the vasodilatory response is not only diminished in diabetics but is 
also related to glycemic control (28), which is supported by findings from in vivo studies 
demonstrating that hyperglycemic spikes induce endothelial dysfunction in both normal and 
diabetic subjects (29,30). Similarly, there are data showing that during the postprandial period in 
diabetic participants, decreased flow-mediated dilation is negatively associated with the extent of 
postprandial glycemia (31). Additionally, rapid upsurges of glucose result in nonreversible 
glycosylation of proteins (32). These advanced glycosylated end-products bind to endothelial 
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smooth muscle receptors, precipitating increased endothelial permeability and vascular smooth 
muscle cell proliferation (2,32). 
Additional avenues by which postprandial hyperglycemia may be mechanistically linked to CVD 
are increased blood coagulation and/or thrombosis. When hyperglycemia is induced 
experimentally, there is an increase in platelet aggregation (33), fragments of prothrombin (34), 
and a shortening of the half-life of fibrinogen (35). There also may be an immune and 
inflammatory component to postprandial hyperglycemia. Increases in TNF-α and IL-6 have been 
shown to occur both in the context of postprandial hyperglycemia (36) and with a hyperglycemic 
clamp (37). In addition, circulating levels of intracellular adhesion molecule-1 (ICAM-1) have 
been demonstrated to increase substantially following post-challenge glycemia, suggesting 
activation of one of the most proximal steps of the atheromatous lesion process (38). Finally, 
LDL oxidation is known to increase in type 2 diabetic patients after meal consumption and is 
inversely proportional to degree of metabolic control (39,40). Collectively, these findings 
provide support for the notion of direct metabolic and physiologic links between 
postprandial/post-challenge hyperglycemia and CVD risk. 
 Triglycerides and Metabolic Status/Risk 
Fasting Triglycerides and Cardiovascular Disease Risk 
Similar to fasting blood glucose, elevated fasting triglyceride levels are typically thought to be a 
risk factor for CVD. However, the data supporting this relationship are somewhat equivocal. It 
appears that, unlike HDL-C and LDL-C for which there are strong, consistent relationships with 
cardiovascular risk (41), the data do not clearly reveal fasting triglycerides to be an independent 
risk factor for CVD. For example, the relationship between triglyceride levels and cardiovascular 
risk, although significant in univariate analyses, sometimes disappears or weakens in 
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multivariate analyses that control for HDL-C (42). In addition, measurement of triglycerides, 
clinically or experimentally, can fluctuate greatly based on recent dietary composition, physical 
activity, or weight status (42,43). However, some evidence does point to the utility of measuring 
fasting triglycerides in order to assess cardiovascular risk (44,45). First, the Copenhagen Male 
Study, which featured an 8-year follow-up of nearly 3,000 middle- to older-aged men, found that 
men in the middle and highest tertile groups of fasting triglyceride levels had an increased risk 
for ischemic heart disease, as well as a risk gradient based on triglyceride levels, even after being 
stratified for HDL-C (44). Intriguingly, the middle and highest tertiles of triglyceride levels 
displayed relative risks for ischemic heart disease of 1.5 and 2.2 respectively, compared to the 
lowest tertile, even after consideration of LDL-C, HDL-C, physical activity, hypertension, type 2 
diabetes, smoking, body mass index, and age (44). Further, a meta-analysis that included 46,413 
men and 10,864 women across 17 population-based, prospective studies found that elevated 
triglyceride levels were associated with a ~30% increase in CVD risk in men and ~75% increase 
in women (45). While controlling for HDL and LDL cholesterol indicated a lowered associated 
risk between triglycerides and CVD, having elevated triglyceride levels was still a statistically 
significant risk factor. 
Postprandial Triglycerides and Cardiovascular Disease Risk 
While the clinical and experimental utility of measuring fasting triglycerides remains equivocal, 
there is substantial evidence suggesting that the transient, extensive rise in blood lipids (namely, 
triglycerides) following a meal can have direct atherosclerotic effects (46). Thus, postprandial 
lipemia is considered by many to be an independent CVD risk factor (2,47). First, whereas the 
relationship between fasting triglyceride levels and cardiovascular risk can be confounded by 
HDL-C levels (42), there are data demonstrating that as triglycerides increase in the postprandial 
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period there is a related decrease in certain HDL-C subfractions (48). Furthermore, postprandial 
levels of certain triglyceride-rich lipoprotein subfractions (particularly, small chylomicron 
remnants) were found to be correlated with coronary lesion progression in 32 post-infarction 
men, even after controlling for HDL-C and dense LDL apolipoprotein B (49). In a landmark 
study by Patsch et al. (46), 40 control subjects, and 61 subjects with severe coronary artery 
disease (CAD), completed meal tolerance tests in order to assess postprandial lipemia and CAD 
risk. Measures of postprandial lipemia (peak and AUC values) were significantly greater in the 
CAD patients than in the controls (46). Furthermore, postprandial lipemic values predicted the 
presence or absence of CAD with 68% accuracy by logistic regression analysis (46). Although 
not synonymous with postprandial triglycerides, non-fasting triglycerides still provide a way to 
examine the blood lipid levels that a person may experience in daily life, and are more practical 
for large-scale studies. In a prospective study of 26,509 initially healthy women, fasting and non-
fasting triglycerides were assessed over ~11 years of follow-up and hazard ratios for incident 
cardiovascular events were determined (50). Although both baseline fasting and non-fasting 
triglyceride levels correlated with cardiac risk factors and markers of insulin resistance, the 
relationship disappeared with regard to fasting triglyceride values after covarying total 
cholesterol, HDL-C, and measures of insulin resistance (50). On the other hand, the relationship 
between non-fasting triglycerides and cardiac events remained robust even in the fully adjusted 
model (increasing tertiles of non-fasting triglyceride levels: 1 [reference tertile], 1.44, and 1.98), 
thus supporting the use of non-fasting (or postprandial) triglyceride measures over fasting 
triglyceride measures when predicting cardiovascular risk (50).    
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Mechanisms Behind Triglycerides and Cardiovascular Risk 
The primary mechanism explaining how elevated triglyceride levels, be it fasting, non-fasting, or 
postprandial, induce CVD is the subendothelial retention of lipoproteins, which initiates 
atherogenesis (51). Circulating chylomicrons and large very low-density lipoproteins (VLDL) 
molecules, which are rich in triglycerides, are too big to penetrate the arterial wall, but smaller 
dense VLDL and other remnant molecules can enter the arterial wall and bind to proteoglycans 
(52). Presence of these lipoprotein and remnant molecules, which can be elevated during acute 
postprandial lipemia, initiates a local inflammatory response that includes macrophages and T-
cells that promote subsequent lesion development (51). This hypothesis is in line with studies 
demonstrating that the extent of coronary blockage and subsequent CVD risk is associated with 
the degree of postprandial lipemia following a high-fat meal (46,49). In addition, there are also 
data suggesting that carotid intima media thickness is significantly positively associated with the 
postprandial lipemic response in both healthy and diabetic individuals (53,54). Further, many 
studies have provided evidence suggesting that markers of inflammation significantly increase in 
the presence of postprandial lipemia, including plasma IL-8, neutrophil counts, ICAM-1, and 
TNF-α (36,55,56).  
Another avenue by which lipemia may increase cardiovascular risk is impaired endothelial 
function. It has been shown that endothelial function, measured as brachial artery blood flow, 
can be impaired in response to a high-fat meal, providing a potential mechanistic link between 
postprandial lipemia and heart disease, independent of cholesterol (57). Interestingly, a study by 
Erridge et al. (58) found a significant increase in circulating bacterial endotoxin following a 
high-fat meal, suggesting that low-grade endotoxemia may contribute to the inflammatory state 
that occurs after a high-fat meal, and may explain the endothelial dysfunction that occurs during 
20 
 
postprandial lipemia. As a whole, evidence suggests several overlapping mechanisms by which 
elevated triglyceride levels, fasting or postprandial, may lead to increased CVD risk. 
 Similarities between Glycemia and Lipemia 
Since postprandial glucose and lipids both appear to fluctuate from homeostasis on a daily basis 
in normal living, and more importantly these aberrant responses appear to be strongly linked to 
cardiovascular risk, it may be worth considering them in unison, compared to independently as is 
currently common practice. However, in order to understand the ways in which glycemia and 
lipemia are linked, it is vital to discuss and recognize the overlapping metabolic pathways shared 
between dietary carbohydrate and lipids. 
Uptake into Peripheral Cells 
Circulating blood glucose is taken up by human cells via facilitated diffusion across the plasma 
membrane. There are at least six known glucose transporters (GLUTs) that perform this task 
(59). GLUT4 is the most widely acknowledged, as it is expressed on adipose cells, skeletal 
muscle cells, cardiac muscle cells and other insulin sensitive cells (60). As insulin binds to its 
receptor, GLUT4 is translocated to the plasma membrane and glucose enters the cell (60).  
There are two primary ways in which lipid (specifically, fatty acids) can become available for 
energy use in the cytosol of a given cell. One option is for fatty acids to diffuse across the plasma 
membrane of the cell, similar to carbohydrate. These incoming fatty acids are either: 1) freed 
from triglycerides in lipoproteins by the action of lipoprotein lipase (LPL); 2) circulating bound 
to albumin; or 3) circulating as free fatty acids. The other option for fatty acids to become 
available in the cytosol is liberation from intracellular lipid pools. Regardless of how they arrive 
in the cytosol, fatty acids are typically found linked to fatty acid binding protein (FABP) (61). 
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In discussing the uptake of fat and carbohydrate into peripheral cells, it is worth considering the 
shared relationship of both glucose and fatty acids with the hormone insulin. As discussed 
previously (see Mechanisms behind blood glucose and cardiovascular risk), insulin works to 
both allow entrance of glucose into peripheral cells as well as suppress the release of free fatty 
acids into circulation. Thus, insulin clearly plays a major role in the regulation of circulating 
glucose and fatty acids. Further, as elevations in circulating free fatty acids can precipitate 
augmented hepatic glucose production (27), perturbations in the level of one substrate can affect 
the other. Therefore, based on the data there is a relationship between an individual’s circulating 
levels of insulin, glucose, and fatty acids, and consequently derangement of one substrate or 
mechanism (e.g. insulin sensitivity) can produce a downward metabolic spiral (25).  
Another relevant consideration when discussing uptake of carbohydrate and lipid is the effect of 
dietary fats on insulin resistance. Evidence suggests that increased levels of fatty acids, both in 
the diet and in circulation, can play a role in development of insulin resistance (62). The level of 
fatty acids in the diet and circulation, as well as a the type, i.e. the proportion of saturated fatty 
acids relative to unsaturated fatty acids, will be reflected in the fatty acid composition of 
peripheral cell membranes (63). Higher levels of saturated fatty acids in cell membranes appear 
to substantially hinder insulin action (62). In addition, as Randle and colleagues (64) first 
suggested in 1963, elevated fatty acids likely compete with glucose for clearance via oxidation, 
resulting in elevated blood glucose, and thus high fatty acid intake can be directly responsible for 
the body’s inability to clear glucose. Over time this could lead to severely impaired glucose 
disposal and overt diabetes. It also appears that high levels of myocellular lipid can impair 
insulin sensitivity (65,66). As the traditional Western diet is typically high in fat, especially 
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saturated fat, these findings represent additional ways in which dietary lipid and carbohydrate 
intake are interconnected in the determination of chronic disease risk. 
Major Metabolic Pathways 
The initial step towards obtaining energy from glucose present in the cytosol is glycolysis, 
followed by the Kreb’s cycle, and the electron transport chain (see reviews: references 67 & 68). 
Glycolysis is a set of ten reactions by which glucose is converted to two molecules of a pyruvate, 
with two adenosine triphosphate (ATP) molecules and one hydrogenated nicotinide adenine 
dinucleotide (NADH) molecule produced in the process. The newly generated pyruvate can have 
one of several different destinations, including entering the mitochondria and being converted 
into acetyl coenzyme A (CoA) via pyruvate dehydrogenase, or being converted to alanine or 
other amino acids, lactic acid, oxaloacetate, or back to glucose.  
In order to obtain energy from the fatty acids located in the cytosol, the final destination is the 
Kreb’s cycle as well, although there is a longer and more complex path. The process of fatty acid 
oxidation, known as beta-oxidation, is a four step process that results in the products flavin 
adenine dinucleotide (FADH2), NADH + H+, and acetyl CoA being produced. The acetyl CoA 
produced via beta-oxidation can either travel to the liver to form ketone bodies or condense with 
oxaloacetate to form citrate and enter the citric acid cycle. (It should be noted that odd-chain 
fatty acids and unsaturated fatty acids require additional steps and/or enzymes compared to even-
chain saturated fatty acids, which were discussed here for simplicity.)  
Acetyl CoA, whether its original source was lipid, carbohydrate, or otherwise, enters the citric 
acid cycle, also known as the Kreb’s cycle, where it condenses with oxaloacetate to form citrate. 
Eight subsequent reactions occur, after which oxaloacetate is again present, thus making the 
process cyclic. During one round of the citric acid cycle, two carbon dioxide molecules, three 
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NADH+ molecules, one FADH2 molecule, and one ATP molecule are generated. NADH+ and 
FADH2 can then transfer their electrons to the electron transport chain, through which oxidative 
phosphorylation produces more ATP.  
An Overwhelmed Pathway 
It is important to consider the postprandial glycemic and lipemic responses together because they 
ultimately share similar destinations or outlets. Although details vary depending on the 
physiologic site, carbohydrates and fats can generally “compete” for clearance from the stomach, 
small intestine, bloodstream, and within the peripheral cell. Specifically with regard to the latter, 
both carbohydrates and lipids are largely converted to acetyl CoA and enter the citric acid cycle 
and the electron transport chain, as previously discussed. Consumption of large-volume, calorie-
dense, and easily-digestible food precipitates substantial spikes in free fatty acids, triglycerides, 
and blood glucose. As the fat and carbohydrate compete for clearance, the excessive upsurge of 
metabolic energy overwhelms the metabolic capacity of the mitochondria within adipose and 
skeletal muscle cells, as well as all other metabolically active cells (69). Fatty acids and glucose 
swamp the citric acid cycle, which promotes the excess production of NADH+ that outperforms 
the electron transport chain (2). The buildup of NADH+ raises the proton gradient within the 
mitochondria, promoting the transfer of single electrons to oxygen, generating free radicals that 
include the superoxide anion (2,70,71). The elevated production of reactive oxygen species will 
subsequently oxidize LDL particles that have penetrated the endothelium and entered the 
subendothelial space (72,73). Oxidized LDL particles lead to an inflammatory cascade in the 
following ways: 1) increased expression of cellular adhesion molecules, which promote 
attachment and penetration of immune cells to the endothelium (74); 2) elevated release of pro-
inflammatory cytokines (75); 3) activation of endothelial and smooth muscle cells (76); and 4) 
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increased uptake of the oxidized LDL particles by M2 macophages, triggering additional release 
of pro-inflammatory cytokines (73). Thus, the subendothelial penetration of lipoproteins and 
their subsequent oxidation by reactive oxygen species – both downstream results of the energy 
excess in circulation – can precipitate increased inflammation, sympathetic tone, and 
vasoconstriction, as well as thrombogenecity and advanced glycation end-products (AGE’s) – all 
of which can increase an individual’s CVD risk (2,69,77,78). So, since both glucose and fatty 
acids can “team up” to overwhelm the metabolic machinery of the body and produce the above 
response, it does not seem unreasonable to consider the glycemic and lipemic responses in the 
postprandial period together. 
 Summing Glucose and Triglycerides to Characterize the “Metabolic Load 
Index” 
Given the potential utility and value in assessing postprandial glycemia and lipemia in unison, 
we suggest a summative index that we have termed “metabolic load index” (MLI).  To create a 
MLI score, the clinician or scientist could simply combine the values of circulating blood 
glucose and triglycerides: 
MLI (mg/dL) = TG (mg/dL) + Glu (mg/dL) 
For instance, if considering a single time point, glucose and triglycerides could be summed to 
determine the metabolic load index in mg/dL for that point in time. The principle would remain 
the same if AUC was being considered: simply sum the triglyceride and glucose AUC values. In 
this way, the researcher and clinician could get an idea of the overall metabolic load, or 
challenge, that the patient or participant is experiencing as well as the volume of circulating 
available energy, either at that specific time point or over time (such as following a meal).  
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Figure 2 demonstrates MLI utilizing published data from our laboratory, which displays hourly 
changes in glucose, triglycerides, and MLI following a high-fat meal (79). The test meal 
consisted of ice cream and whipping cream (1 g/kg body weight carbohydrate and 1 g/kg body 
weight fat, ~60% fat, 20% carbohydrate). Metabolic load index is the sum of triglycerides and 
glucose at each time point. It is interesting to note that, since the meal contained ~60% fat, the 
MLI closely follows the change in triglycerides over time, most likely due to the large 
contribution of fat to the total calories of the meal. Similarly, as the carbohydrate load in the 
meal was relatively low, the blood glucose response was marginal and negligibly impacted the 
MLI during the postprandial period. This test meal was high in fat and few people would likely 
deem the meal “healthy”. However, if blood glucose response was the main/only outcome of 
interest, the conclusion after consumption of such a meal could be that metabolic disturbance 
was minimal, although this is clearly not the case when the triglyceride and MLI responses are 
considered together. Thus, clinically, assessment of MLI could provide a measurement of 
metabolic challenge or disturbance without biasing towards glucose or triglycerides alone. 
Further, consideration of MLI may be more relevant when determining metabolic responses to 
mixed meals that are more typically consumed in daily living, as compared to an all-lipid or all-
carbohydrate meal, as is used in an OGTT. 
To support this notion, there is evidence indicating that postprandial fat and carbohydrate 
metabolism are not independent processes and alterations in one can affect the other. An early 
study elucidating this relationship was conducted by Albrink and colleagues (80) in 1958 in 
which a 60 g fat meal was consumed with and without 100-250 g of added glucose. The authors 
found that the addition of glucose either diminished or completely abolished the postprandial rise 
in triglycerides, depending on the amount of added glucose (80). In a related study several years 
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later, Mann et al. (81) found that postprandial lipemia was cleared more slowly following a meal 
that contained a glucose load compared to a meal that contained sucrose. These early findings 
have been supported by several more recent studies demonstrating similar results (82,83,84). In a 
randomized crossover study, Westphal et al. (84) investigated the effect of adding 75 g of 
glucose to a high-fat meal compared to a high-fat meal without the added glucose on 
triglycerides, VLDL, and chylomicrons. The addition of glucose to the meal resulted in a delay 
in the triglyceride response, as well as a lower peak (84). There was also a 42% reduction in 
incremental AUC for the meal with glucose compared to the fatty meal alone. Finally, there was 
a delayed chylomicron response and a blunted VLDL response. A similar investigation by Knuth 
et al. (83) demonstrated a reduction in postprandial plasma triglycerides in women following a 
fat meal containing additional carbohydrate compared to a fat meal alone. Collectively, these 
studies suggest that the addition of carbohydrate to a meal and the resultant glycemic response 
alters the postprandial rise in triglycerides. The interrelationship between postprandial glycemia 
and lipemia also holds when adding fat to a high-carbohydrate meal (85,86). In an investigation 
by Collier and O’Dea (85), when 50 g fat (as butter) was added to 50 g carbohydrate (as potato), 
the postprandial glucose response was significantly blunted compared to ingestion of potato 
alone. This mitigation was likely a result of delayed glucose absorption in the small intestine, 
consequent to a fat-induced repression of gastric emptying. Together, these findings suggest that 
postprandial glucose and lipid metabolism are not independent processes – rather they are 
interrelated, and consequently it would be valuable to consider them together.  
There may also be merit in considering an energy-adjusted version of the MLI. Lipid typically 
yields ~9 kcal/kg and carbohydrate yields ~4 kcal/kg. In an attempt to consider the amount of 
circulating energy in the bloodstream at a given time, there may be utility in adjusting the 
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metabolic load index equation to reflect the difference in energy yield between carbohydrate and 
fat, which could be accomplished via an “Adjusted Metabolic Load Index”, or A-MLI: 
AMLI (in kcal/dL) = (TG (in mg/dL) x 0.001 g/mg x 9 kcal/g) +  
(Glu (in mg/dL) x 0.001 g/mg x 4 kcal/g) 
For instance, if an individual was found to have triglyceride levels of 120 mg/dL and glucose 
levels of 90 mg/dL, their A-MLI would be 1.44 kcal/dL. Thus, the A-MLI would provide an 
equation through which to quantify or estimate the available circulating energy from fat and 
carbohydrate. However, there are some issues with the A-MLI, which include biasing towards 
triglycerides and presenting somewhat unusual units (kcal/dL). Nevertheless, the A-MLI may 
prove to be a valuable clinical tool in assessing the metabolic state. Research comparing MLI 
and A-MLI with regard to prediction of and association with health outcomes would be valuable. 
Utility of the Metabolic Load Index 
What are some ways or instances in which utilization of the MLI would be beneficial or enhance 
our understanding of an individual’s metabolic status? First and most clearly, use of the (MLI) 
could better reveal the degree of metabolic challenge that a person is experiencing either while 
fasting or after a meal. This utility would be particularly applicable to patient populations, as it 
has already been previously discussed how fluctuations in postprandial glycemia and lipemia can 
be cardiovascular risk factors. Specifically, it may be valuable to develop a “cut point” for 
fasting MLI, such as 200 mg/dL, since postprandial assessments may be too cumbersome in 
certain clinical settings. Particular patient populations for which assessing MLI would be 
valuable might include individuals with diagnosed cardiovascular disease or type 2 diabetes. 
Since metabolism of lipids and carbohydrates is so interrelated, consideration of the glycemic or 
lipemic response together would be valuable.  
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Metabolic load index would also be useful in terms of standardizing responses across studies 
investigating postprandial metabolism. One of the most difficult aspects of compiling and 
comparing studies either investigating postprandial lipemia or glycemia (when a mixed meal is 
used) is the heterogeneity of test meal challenges that are utilized in the investigations. While 
differences in the amount of total energy (and perhaps participants’ body mass) would still need 
to be considered, MLI may help in comparing across studies that use meals of different 
macronutrient distribution but similar caloric value.  
A current area of debate is the ideal proportion of macronutrients that should be consumed in a 
healthy diet. If the MLI response is similar between diets of different macronutrient distribution 
but similar caloric load, it may make the focus on select macronutrient profiles less prevalent.  
Considerations of the Metabolic Load Index 
Given the novelty of the MLI, there are certainly considerations to be made. First, it has been 
shown that dietary fructose leads to different postprandial metabolic responses than dietary 
glucose (87). Specifically, fructose consumption (compared to glucose) as part of a mixed meal 
will lead to 1) a greater triglyceride response, particularly in the latter stages of a postprandial 
assessment; 2) a comparatively negligible glucose response; and 3) a much more tempered 
insulin response (87). However, we assert that the different metabolic responses of glucose and 
fructose do not represent a weakness of MLI, but rather a strength. Considering the different 
metabolic consequences of glucose and fructose, the outcomes of interest are nevertheless the 
same: circulating glucose and triglycerides, the two markers measured in the MLI. Thus, while 
fructose may lead to a greater triglyceride response and a lesser glucose response compared to 
dietary glucose (87), this will be captured in the MLI. If only considering the blood glucose 
response, one could surmise that fructose is better to include in a mixed meal because there is a 
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much less blood glucose response. However, utilizing the MLI, it can be seen that fructose still 
has substantial metabolic effects – though it more drastically alters the other component of the 
MLI equation, triglycerides. Thus, we assert that a strength of MLI is that it “throws a broader 
net”. In other words, even though many nutrients clearly have differing metabolic effects, such 
as glucose and fructose, MLI is better equipped than blood glucose or triglyceride assessment 
alone to capture the metabolic challenge that the body is experiencing. 
It would be valuable to determine an optimal postprandial time point to assess MLI. For instance, 
it appears that triglycerides measured two and four hours after meal consumption have the 
strongest association with cardiovascular events (50) and that triglycerides tend to peak four 
hours after a meal (88,89). Additionally, one study has found that measuring triglycerides four 
hours post-HFM is a suitable surrogate for longer and more involved postprandial lipemia 
assessments (90). On the other hand, as previously discussed, post-challenge glucose tolerance is 
typically assessed in the context of a two-hour OGTT (11) and two-hour glucose values are 
strongly related to CVD risk (12,13,14). Clearly, there are differences in the timing of 
postprandial glucose and triglyceride responses, and consequently the timing of assessment to 
best ascertain an individual’s disease risk. Considering these differences, it is difficult to state an 
optimal, single time point at which to assess MLI in clinical and research settings. It would be 
very worthwhile for future studies to address this question using large datasets of postprandial 
metabolic markers and disease risk outcomes. 
Similarly, a logical question is: which individuals would benefit most from ascertaining their 
fasting and postprandial MLI? An expert panel statement has suggested that postprandial 
triglyceride assessments are most valuable in individuals with fasting levels between 89-180 
mg/dL (91). The rationale for this stance is that individuals with fasting triglycerides <89 mg/dL 
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will typically show a negligible postprandial response, while those with fasting triglycerides 
>180 mg/dL will present an excessively delayed and exaggerated postprandial lipemic response, 
such that there is little diagnostic utility (91). In line with this, there may be certain populations 
that could most benefit diagnostically from determination of MLI. It could be that individuals 
with very low or high fasting glucose and/or triglyceride levels may not benefit very much from 
the additional metabolic information provided via MLI. However, we are hesitant to state which 
individuals would and would not benefit from fasting and postprandial MLI assessment, given 
the current dearth of evidence to support a conclusion. Further, as addressed previously, with 
both glucose and triglycerides, postprandial values are typically better predictors of CVD risk 
compared fasting values. Thus, there is not compelling evidence suggesting that individuals with 
certain fasting MLI values would not benefit substantially from a postprandial MLI assessment. 
It would be advantageous for future research to further explore this concept. 
Finally, it is likely that genetics influence the postprandial MLI response. This supposition is 
based on the notion that gene variation has been found to contribute to inter-individual 
differences in both postprandial lipemia and hyperglycemia. With regard to postprandial lipemia, 
the most heavily studied genetic regions have been the encoding of various apolipoprotein genes, 
such as APOA1 (92) and APOC3 (93), and genes encoding lipid metabolism enzymes, such as 
LPL (94) and HL (hepatic lipase) (95). A few areas of genetic contribution to hyperglycemia 
include adiponectin gene polymorphisms (96,97), telomere length (98), and TCF7L2 variation 
(99), a transcription factor that is to date the most substantial genetic contributor to type 2 
diabetes incidence (100). Clearly, as there are established genetic contributors to both 
postprandial lipemia and hyperglycemia, it is logical to assume genetic factors influence MLI as 
well. 
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 Conclusion and Future Directions 
It has been well-established that postprandial glycemia and lipemia are risk factors for CVD. 
Specifically, postprandial glycemia and lipemia have been linked to increased disease risk by 
way of oxidative stress, inflammation, and endothelial dysfunction, as well as other mechanisms. 
Although carbohydrate and lipids ultimately share similar clearing mechanisms, the fluctuations 
in these substrates in daily life, or experimentally following a test meal challenge, have 
historically only been considered separately. However, in light of evidence that postprandial 
glycemia and lipemia are not independent of one another, it does not seem unreasonable to 
consider both of these phenomena together in a single index. The concept of metabolic load 
index, which is the sum of blood glucose and triglycerides, is valuable in that it considers the 
total metabolic challenge that the body is experiencing, either at a single time point, or over time. 
In our opinion, the MLI carries significant potential clinical utility. It would be worthwhile for 
future investigations to assess MLI in the context of disease risk, investigating the relationship 
between MLI and markers of inflammation, oxidative stress, endothelial dysfunction, and other 
risk markers. However, currently we do not know whether adding the two outcomes in a one to 
one ratio is the most accurate way to predict risk when considering glucose and triglycerides 
together. Thus, future work should seek to derive the best equation for assessing glycemia and 
lipemia simultaneously by using data from clinical populations and longitudinal studies.  
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 Figures 
 
Figure 2-1. Postprandial lipemia, postprandial hyperglycemia, and cardiovascular disease 
risk. 
Multiple potential mechanisms exist to explain the connection between postprandial 
dysmetabolism (glycemia and lipemia) and cardiovascular disease risk. Similar primary facets 
involved in both postprandial glycemia and lipemia are elevated markers of systemic 
inflammation, increased subendothelial retention of lipoproteins, and increased intracellular 
adhesion molecules. See Mechanisms behind blood glucose and cardiovascular risk and 
Mechanisms behind triglycerides and cardiovascular risk for more detail.  
VLDL, very low-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; FFA, 
free fatty acids; ROS, reactive oxygen species. 
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Figure 2-2. Hourly changes in glucose, triglycerides, and metabolic load following a high fat 
meal. 
These data were taken from a previously published study in our laboratory.(79) This figure 
displays glucose (●), triglyceride (■), and metabolic load index (Δ) at baseline (time 0) and for 
eight hours during the postprandial period following consumption of a high-fat meal. With this 
data, fasting and postprandial metabolic load index can be determined by adding the triglyceride 
and glucose value at each time point. See Part V – Summing glucose and triglycerides to 
characterize “Metabolic Load Index” for more detail. Data are Mean ± SEM. 
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Figure 2-3. Postprandial triglyceride responses to a high fat meal with (▲) and without (□) 
75 g of added glucose. 
The triglyceride response is blunted in terms of both peak value and time to peak when glucose 
is added to the high fat meal. Incremental AUC is 42% lower in the fat meal with added glucose 
compared to the fat meal alone (see legend). Adapted with permission from Westphal et al. (84). 
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Chapter 3 - Magnitude and Timing of the Postprandial 
Inflammatory Response to a High-fat Meal in Healthy Adults: A 
Systematic Review 
 Abstract 
Research findings over the past several decades have revealed that inflammation is a prominent 
feature of many chronic diseases, with poor diet being one likely inflammatory stimulus. 
Specifically, a single high-fat meal (HFM) has been suggested to increase inflammation, 
although there is currently no consensus regarding the specific changes of many of the pro-
inflammatory markers that are frequently assessed after a HFM. The aim of this systematic 
review was to objectively describe the postprandial timing and magnitude of changes of five 
common inflammatory markers: interleukin (IL)-6, C-reactive protein (CRP), tumor necrosis 
factor (TNF)-α, IL-1β, and IL-8. Ten relevant databases were searched, yielding 494 results, of 
which 47 articles met the pre-established inclusion criteria: 1) healthy men and women age 18-60 
years; 2) consuming a single HFM (≥30% fat, ≥500 kcal); and 3) assessing relevant 
inflammatory markers post-meal for ≥2 hours. The only marker found to consistently change 
(increase) in the postprandial period was IL-6 – on average starting at a baseline of ~1.4 pg/mL 
and peaking at ~2.9 pg/mL approximately 6 hours post-HFM (an average relative change of 
~100%). C-reactive protein, TNF-α, IL-1β, and IL-8 did not change significantly in 79% (23/29), 
68% (19/28), 67% (2/3), and 75% (3/4) of included studies, respectively. We conclude that there 
is strong evidence that CRP and TNF-α are not responsive at the usual time scale observed in 
postprandial studies in healthy humans younger than age 60 years. However, future research 
should further investigate the role of IL-6 in the postprandial period, as it routinely increases, 
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even in healthy participants. We assert that the findings of this systematic review regarding 
markers of inflammation in the postprandial period will considerably aid in informing future 
research and advancing clinical knowledge. 
 Introduction 
Cardiovascular disease (CVD) is widely recognized to be the leading cause of death in the 
United States and throughout Western society (1). Lifestyle factors that appear to increase risk 
for CVD include insufficient physical activity (2), obesity (3), and poor dietary habits (4). While 
the causal factors leading to the manifestation of CVD are certainly complex and numerous, it 
has become clear that a common feature of heart and vascular diseases is inflammation (5). 
Atherosclerotic lesions, a prominent feature of CVD, are a hotbed of inflammatory activity. 
Briefly, immune cells such as T-cells, macrophages, and mast cells will infiltrate into an 
atheromatous lesion, where they can: 1) promote prothrombotic factors, 2) cause the release of 
metalloproteinases and cysteine proteases that can reduce the stability of the atherosclerotic 
plaque, and 3) promote the release of pro-inflammatory cytokines, such as interleukin (IL)-6 and 
tumor necrosis factor alpha (TNF-α) (6). These acute markers of inflammation then travel to the 
liver, whereby they stimulate the increased release of chronic, low-grade markers of 
inflammation, such as C-reactive protein (CRP). Excessive inflammation is positively associated 
with type 2 diabetes, obesity, and coronary artery disease (7,8).  
But what are the stimuli that jumpstart the deleterious inflammatory cascade? A commonly 
suggested inflammatory stimulus is a chronic high-fat diet. Indeed, when rodents are fed a high-
fat diet, there is an increase in markers of inflammation both in adipose tissue and in systemic 
vasculature (9,10,11). Thus, a diet high in fat and overall energy may partly cause the elevated 
systemic inflammation that underpins cardiovascular disease, as well as insulin resistance, and is 
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associated with obesity (12). However, the effect of dietary consumption on inflammation may 
not be limited to chronic intake, but may be evident after consumption of a single meal.  
To this end, numerous studies have been undertaken to investigate the effects of a single high-fat 
meal (HFM) on postprandial inflammation (see Table 1 and Supplemental Tables 1-4). Many 
studies have found a significant increase in markers of systemic inflammation following a HFM, 
while others have found no changes. Study design variables that could potentially affect relevant 
findings and consequently precipitate inter-investigation differences include meal size, meal 
composition, subject characteristics, previous acute exercise, postprandial period assessment 
length, and method of drawing blood. As a result, we are currently far from consensus with 
regard to the response features (i.e. timing and magnitude) following a HFM of even the most 
commonly assessed markers of inflammation. A synthesis of previous research investigating 
postprandial inflammation, with particular attention to the specific features of the response, 
would inform future research and advance clinical understanding. 
Therefore, the purpose of this systematic review was to characterize the postprandial 
inflammatory response, in terms of magnitude and timing, to a HFM in healthy men and women 
(age 18-60) based on the consolidated findings of previous relevant investigations. The markers 
of inflammation included in the present review include IL-6, IL-1β, IL-8, TNF-α, and CRP, as 
these are frequently assessed inflammatory markers in the postprandial period. 
 Methods 
Inclusion Criteria 
In order to be incorporated into the present systematic review, there were multiple inclusion 
criteria that each study was required to meet. Individuals being assessed were to be human men 
or women of age 18-60 years. Participants had to be healthy and not diagnosed with any chronic 
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disease. Studies featuring overweight and obese participants were included in the analyses as 
long as they did not present with any other chronic disease. The study must have included a 
HFM challenge that provided at least 500 kcal of energy with at least 30% of the energy from 
fat. The study needed to feature a single meal, or studies with serial meals provided in the 
postprandial period were included if there were data included for time points prior to the second 
meal. Any data reported after a second meal were excluded from the present analyses. If a study 
contained multiple meal trials or subsets of participants, each meal or participant group that met 
the inclusion criteria was considered separately. If a study included an exercise session, only the 
control (no exercise) condition was included. In order to be included, each study must have 
assessed one or more of the previously stated markers of inflammation (IL-6, IL-1β, IL-8, TNF-
α, and CRP), both at baseline (fasting) and in the postprandial period for at least 2 hours. Only 
data from full-text, peer-reviewed and published articles were included (i.e. data from conference 
proceedings, abstracts, and textbooks were not included). There were no restrictions on year of 
publication, but only English-language articles were included. If a study did not satisfy all of the 
aforementioned criteria, it was excluded from the present systematic review. 
Search Strategy 
Article searches occurred in January and February of 2016. Automatic searches recurred weekly 
throughout manuscript preparation in order to capture very recent publications. However, 
recurring automatic searches produced no new articles. Databases that were searched include: 
NCBI Pubmed, Scopus, Proquest Nursing and Allied Health, Web of Science, Cochrane Library, 
SpringerLink, SPORTdiscus, Health and Wellness Resource Center, Health Reference Center 
Academic, and PsycINFO. Key search terms were: postprandial or post prandial; high fat meal; 
inflammat* or cytokine or interleukin; healthy or normal; and humans or men or women. 
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Appropriate search modifiers were used to exclude children, elder*, rodents, rats, and mice. 
Articles retrieved during searching were imported into and catalogued using Refworks reference 
management software (ProQuest LLC, Ann Arbor, MI). The process and results of the 
systematic search are displayed in Figure 1. There were 494 total citation hits from all databases 
combined. Of these, 163 citations were eliminated as duplicates (75 duplicates were retained). Of 
the 331 citations that passed the duplicate check, 103 citations were eliminated on the grounds of 
not being full-text peer-reviewed research articles. The remaining 228 articles were assessed 
based on aforementioned criteria, in abstract-form only, by two independent reviewers (SRE and 
SPK). The reviewers then met to discuss inclusion/exclusion of each abstract and 156 articles 
were eliminated. Of the eliminated articles, 88 papers were eliminated due to not being 
postprandial studies assessing responses to a meal. The other 68 abstracts that were postprandial 
studies were eliminated due to not testing humans age 18-60 years (8 articles), participants 
presenting with a chronic disease (12 articles), not utilizing test meals that were at least 500 kcal 
and 30% fat (9 articles), and/or not testing one or more of the relevant inflammatory markers (51 
articles). The remaining 72 articles were retrieved in full-text form and given thorough 
assessment by both reviewers. Finally, 25 articles were eliminated following full-text 
assessment, leaving 47 articles to be included in the final analyses. The reasons for the 
eliminated 25 full-text articles are detailed in Figure 1. Some abstracts and full-text articles were 
eliminated for not complying with multiple inclusion criteria. 
Data Extraction 
Information regarding the test meal (composition, fat and energy content), participants (number 
of participants, male/female ratio, and age and BMI of participants), blood draw method (cannula 
or repeated venipuncture), and length of postprandial assessment were extracted from each study. 
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In addition, for each inflammatory marker of interest (IL-6, IL-8, IL-1β, TNF-α, and CRP), the 
following information was extracted: whether or not the marker significantly changed from 
baseline, the fasting value, the time to peak or nadir (if applicable), and the peak or nadir value 
(if applicable). For many studies, all of the necessary information was not explicitly included in 
the manuscript. In these cases, authors were directly contacted in order to obtain the missing 
information. Many authors provided the missing information (see Acknowledgements), although 
some did not; thus, some data are missing from the present analyses. 
Assessing Risk of Bias 
A quality appraisal or risk of bias assessment was conducted for all 47 articles included in the 
analyses. All of the included studies utilized the same general study design, therefore traditional 
quality appraisal assessment tools were not applicable to the present systematic review. 
Consequently, we developed an internal validity checklist in order to assess the strength of each 
study. This tool included nine criteria based on different components of postprandial 
inflammation study design: control of diet, fasting quality control, control of exercise, sample 
size adequacy, postprandial period length, blood draw frequency, blood draw method, 
normalization of test meal, and proper processing of inflammatory marker analyses. Each study 
was assessed against the above criteria and given a score ranging from 0-9. Studies were scored 
separately by two independent reviewers (SRE and SPK), after which the reviewers met to 
confirm a final score for each study. 
Statistical Analyses 
Data analyses were performed using GraphPad Prism (Version 6.05; GraphPad Software, Inc; La 
Jolla, CA) and SPSS Statistics software (v.22; SPSS, Inc; IBM Corporation; Armonk, NY). The 
primary outcome measures in this review were mean baseline and peak values and the time-to-
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peak value for each marker of inflammation (in some studies, certain inflammatory markers were 
found to decrease, in which case the nadir and time-to-nadir values were utilized). Fasting and 
peak values for each inflammatory marker were assessed for objective statistical outliers using 
the ROUT method (50), which utilizes nonlinear regression, in GraphPad Prism. The Q value (or 
maximum false discovery rate) was set at 1%. The ROUT method involves three steps. First, a 
robust nonlinear regression is employed to fit a curve that is not affected by outliers. Second, the 
residuals of the robust regression are assessed to determine whether or not there are any outliers. 
The third step of the ROUT method is simply removing the outliers from the dataset. Nine 
outliers (seven fasting values and two peak values) were removed from the IL-6 dataset, one 
outlier (a fasting value) was removed from the CRP dataset, and seven outliers (four fasting 
values and three peak values) were removed from the TNF-α dataset. The datasets for IL-8 and 
IL-1β were too small for outlier analyses, and thus all values were retained. For analyses of 
changes/differences between baseline and peak values, if there was no significant change post-
meal for a given marker in a study, the baseline value was used as both the fasting value and the 
peak value in order to have a complete dataset and not bias the findings toward a significant 
change. (Many studies did not report a post-HFM value in the event of no statistically significant 
change. Thus, in the original analyses, in all studies that did not find a significant change after 
the meal, the baseline value was used as the post-meal value. However, a secondary analysis that 
included post-HFM values of studies that did not find a statistically significant change (when 
available) did not appreciably change the results. Also, the studies that did report a statistically 
non-significant post-meal value generally did not find a biologically significant change either.) A 
paired t-test was used to assess differences between mean baseline and peak IL-6 values from 
each study. This analysis was only performed for IL-6 because most studies found no significant 
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change in the other markers post-meal. Spearman rank correlations were used to assess 
relationships between percent change in IL-6 (from fasting to peak) and mean participant BMI, 
mean participant age, energy content (in kcal) of the test meal, and percent energy content from 
fat in the test meal. As BMI and percent change in IL-6 were not normally distributed, they were 
transformed using the Log-10 method. Data are presented as Mean ± SD. For all relevant 
analyses, the p-value was set at less than 0.05. 
 Results 
Table 1 and Supplemental Tables 1-4 display the extracted information from each study 
separated by respective marker of inflammation. Some studies are represented in multiple tables, 
as they assessed more than one of the relevant markers of inflammation. For IL-6, 32 of 45 
studies (~71%) found a significant increase in the marker following HFM consumption. Ten 
studies (~22%) found no change in IL-6 post-HFM, two studies (~4%) found a significant 
decrease, and one study did not report whether or not the marker changed. Of the 32 studies that 
found a significant increase, two used repeated venipuncture and thirty utilized a cannula. In 
studies that found a significant change post-HFM, the time to peak was 5.9 ± 2.0 hours. For 
twenty-two of the 34 studies that found a significant postprandial IL-6 change, the mean peak 
value occurred at the final time point assessed in the study protocol. Prior to removal of outliers, 
the baseline (fasting) and peak IL-6 values for all studies combined was 4.83 ± 8.02 pg/mL and 
4.76 ± 6.87 pg/mL, respectively. Following outlier removal, the mean baseline and peak values 
were 1.37 ± 0.93 pg/mL and 2.85 ± 1.85 pg/mL, respectively. The mean percent change from 
baseline to peak (following outlier removal) was 153 ± 256 %. After removal of outliers, but 
including studies that found no change or a decrease in IL-6 post-HFM, there was a significant 
increase (p < 0.0001) in IL-6 from baseline to peak value. Figure 2A displays the IL-6 change 
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from fasting to peak for each individual study (following outlier removal) and the mean 
response.  
Twenty-nine studies met the inclusion criteria and measured CRP in the postprandial period. Of 
these, 23 studies (~79%) found no change in CRP in the assessed postprandial period. Four 
studies (~14%) found an increase and two studies (~7%) found a decrease in CRP after the meal. 
Of the studies that found an increase, the peak occurred at 4.7 ± 2.3 hours post-HFM. The fasting 
value for CRP was 1.50 ± 1.15 mg/mL before outlier removal and 1.35 ± 0.86 mg/mL after 
outlier removal. Three of the four studies that found a significant increase in CRP post-HFM did 
not report the peak value; thus, a mean peak value has not been calculated. Figure 2B displays 
the mean and individual responses of CRP to a HFM for all studies. 
TNF-α was assessed in 28 of the included studies. Five studies (~18%) found an increase, four 
studies (~14%) found a decrease, and nineteen studies (~68%) found no significant change in 
TNF-α from baseline during the postprandial period. Prior to removal of outliers, fasting and 
peak TNF-α values were 33.5 ± 143.5 pg/mL and 102.0 ± 242.0 pg/mL, respectively. After 
removal of outliers, the fasting and peak values were 2.76 ± 1.95 pg/mL and 2.85 ± 2.02 pg/mL, 
respectively. In the studies that found a significant post-meal TNF-α increase, the peak occurred 
at 5.5 ± 3.0 hours. In the studies that found a decrease, the nadir occurred at 7.5 ± 1.0 hours. 
Figure 2C provides a visual representation of change or stagnation of TNF-α following HFM 
intake for the studies that passed the outlier check. 
With regard to IL-1β, three studies assessed this marker in the postprandial period. Two studies 
found no significant change from baseline during the postprandial period, while one study found 
a significant decrease. In this study, the mean nadir value occurred at four hours post-meal. 
Figure 2D displays fasting and postprandial values for the three studies that measured IL-1β.  
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Four studies measured IL-8 in the postprandial period. Of these, one study found a significant 
increase in IL-8 from baseline to peak and three studies found no change. The baseline value for 
IL-8 was 2.29 ± 0.36 pg/mL. In the one study that found a significant increase, a peak value of 
3.26 ± 2.56 pg/mL was found four hours after the HFM. Figure 2E shows the mean and 
individuals values for IL-8 at baseline and post-meal for the four respective studies.  
Figures 3A-D show correlations of the percent change in IL-6 from fasting to post-meal with 
different independent variables that could potentially affect the IL-6 response. There was a 
significant negative correlation (ρ = -0.42; p = 0.02) between the percent of energy from fat in 
the test meal and the percent change in IL-6 (Figure 3A). There was not a significant correlation 
(ρ = 0.23; p = 0.26) between the energy content of the test meal and the percent change in IL-6 
(Figure 3B). Similarly, mean BMI showed no significant relationship (ρ = -0.12; p = 0.55) with 
the percent change in IL-6 (Figure 3C). Finally, there was not a significant negative correlation 
(ρ = -0.28; p = 0.16) between mean age of the participants and the percent change in IL-6 (Figure 
3D). 
The results of the quality appraisal for each study are displayed in Table 1 and Supplemental 
Tables 1-4. There was little variability in quality assessment scores among studies, ranging from 
2.5 to 6.5 points out of a possible 9 points. Generally, no differences were observed between 
studies with regard to appraisal score and whether or not a postprandial inflammatory change 
was detected. Since the quality appraisal scores did not noticeably impact our primary outcomes, 
we did not adjust analyses to weight studies differently based on appraisal score. Further, as the 
research questions primarily involved calculation of baseline and peak means in inflammatory 
markers (as opposed to effect sizes of interventions, etc.), the present analyses did not fit well 
with traditional meta-analyses statistics conducted within systematic reviews. 
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 Discussion 
Main Findings 
The purpose of this systematic review was to characterize the magnitude and timing of changes 
in markers of inflammation following HFM consumption, utilizing methodically selected 
research articles that met pre-established criteria. The primary findings were that: 1) very often, 
there was a postprandial increase in IL-6; 2) IL-6 typically peaked at approximately 2.9 pg/mL, 
or, more relatively, exhibited a ~100% increase from baseline, that typically occurred 
approximately 5.9 hours after the HFM; 3) TNF-α and CRP were assessed many times and yet 
very infrequently showed an increase post-HFM; 4) IL-8 and IL-1β have only rarely been 
assessed post-HFM in studies meeting our criteria; and 5) in studies that did assess IL-8 and IL-
1β, although equivocal, the data suggested that these markers of inflammation did not 
significantly change after consumption of a HFM. We believe that these findings are likely to be 
instrumental in advancing our understanding of the immune and inflammatory status of healthy 
individuals before and after HFM intake, and will have utility in designing and interpreting 
future research.  
Importance of Postprandial Metabolism 
Why should we be concerned with the timing and magnitude of inflammatory cytokine responses 
following HFM ingestion? It is because substantial research points to the notion that persistent 
low-grade inflammation is an underlying factor in several high-mortality chronic diseases, and 
that diet can contribute to, or attenuate, that inflammation (5). It was previously thought that 
atherosclerosis was a lipid-storage disease (7). However, we have come to realize the vital role 
of inflammation in the etiology of vascular diseases (5,6,51). To be sure, lipids play a role in the 
disease process, as subendothelial penetration and retention of lipoproteins can serve as an 
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initiating event for the atherosclerotic cascade (52). However, once the lipoproteins are in the 
endothelium, oxidative stress and inflammation processes assume a prominent role (6,7). The 
lipoproteins are oxidized by reactive oxygen species, forming oxidized low-density lipoproteins 
(LDL). Oxidized LDL particles have several pro-inflammatory effects, including: 1) increased 
expression of adhesion molecules (such as vascular cell adhesion molecule 1 (VCAM1) and 
intercellular adhesion molecule 1(ICAM-1)), which promote the adhesion and penetration of 
immune cells to the endothelium (53); 2) increased pro-inflammatory cytokine release (54); and 
3) activation of smooth muscle and endothelial cells (55). In turn, the increased presence of 
immune cells, via the functions of adhesion molecules, further increases the oxidation of 
lipoproteins (7). Many oxidized LDL particles will be phagocytically ingested by macrophages. 
These macrophages, formerly monocytes, are present consequent to their recruitment by 
inflammatory mediators, such as cytokines, and the linkage and induction properties of adhesion 
molecules (6). When monocytes penetrate the endothelium, they differentiate into macrophages. 
Macrophages play a crucial role in the inflammatory processes that characterize atherosclerosis. 
Macrophages present cell surface receptors which, when activated, result in the increased 
production of many pro-inflammatory cytokines and adhesion molecules (56). Further, as 
macrophages become increasingly lipid-laden, as a result of oxidized lipoprotein phagocytosis, 
they will be laid down in the endothelium as foam cells, which are the hallmark cells of the 
atherosclerotic process and promote the progression of intima media thickness (6).  
The increased production of pro-inflammatory cytokines throughout the process outlined above 
is important considering their physiological effects. First, cytokines act as intermediary 
messengers, recruiting immune cells such as monocytes, dendritic cells, and lymphocytes to the 
site of vascular damage, increasing the inflammatory tone of the endothelium (57). Further, it 
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appears that inflammatory cytokines promote the activation of vascular smooth muscle and 
increase vascular sympathetic tone. These effects are evidenced by increased systolic blood 
pressure, decreased flow-mediated dilation, reduced release of the vasodilator nitric oxide, and 
decreased nitroglycerin-induced vasodilation (58). There is, also, evidence that pro-inflammatory 
cytokines, such as IL-6 and TNF-α, directly increase insulin resistance in adipocytes (59). 
Finally, locally produced pro-inflammatory cytokines often travel to the liver and increase the 
production of acute phase response proteins, such as CRP and serum amyloid A (SAA) (6,12). 
CRP and SAA are strongly associated with chronic disease risk. Briefly, CRP levels have been 
shown to be predictive of, among other things, peripheral vascular disease (60), future 
cardiovascular events (61), and ischemic stroke and transient ischemic attack (62). Similarly, 
SAA levels have been shown to be associated with coronary artery disease and future 
cardiovascular events (63). However, evidence implicating markers of inflammation with CVD 
are not limited to acute phase response proteins. Elevated levels of IL-6 in circulation are 
associated with myocardial infarction (64), mortality (65), and type 2 diabetes (66). Evidence 
linking inflammatory marker levels to chronic disease also exists for TNF-α (67), IL-1β (68), and 
IL-8 (69). Clearly, there is a connection between elevated markers of systemic inflammation and 
the development of disease. 
The connection between diet and systemic inflammatory tone has often been suggested (70,71).  
Several studies have investigated potential single-meal effects on markers of inflammation, with 
most studies utilizing HFMs. However, as evidenced by our findings, there is inconsistency and 
ambiguity between studies with regard to the “normal” inflammatory response to a HFM. A 
recent review (12) performed a similar systematic search (with slightly different 
inclusion/exclusion criteria) and compilation of findings, but the authors elected to not quantify 
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the collective response characteristics across studies. In the context of the equivocal nature of the 
postprandial inflammation research findings to date, as well as considering the physiologically 
important implications of altered inflammatory marker levels, the present systematic review was 
conducted to better inform future research studies, as well as advance our understanding 
regarding which inflammatory markers are responsive in the transient window following HFM 
intake. 
Findings for Individual Inflammatory Markers 
The present review found that the majority of studies detected an increase in IL-6 following 
consumption of a HFM, agreeing with the findings of Herieka and Erridge (12). The rise is 
generally robust, as the average relative increase is ~100% of the baseline value; thus, IL-6 is 
quite responsive to HFM intake. It has been suggested that detected increases in IL-6 in the 
postprandial period should be viewed with skepticism, since the process of cannulation has been 
shown to lead to increases in local IL-6 production (72). Indeed, it has been demonstrated that 
cannulation without HFM consumption can lead to increases in IL-6 that are similar to those 
seen after HFM intake (73). In the present review, the vast majority of articles (30/32) that found 
a significant increase in IL-6 post-HFM utilized the insertion of a cannula for repeated blood 
sampling. Thus, it is possible that in these studies some or all of the increase in IL-6 could be an 
artifact of a local inflammatory response to the cannula, as opposed to a systemic response to the 
meal. However, two important points should be considered. First, two studies in our analysis 
utilized repeated venipuncture for blood sampling and found significant postprandial increases in 
IL-6 (35,49). Second, one study (25) found both a significant increase in circulating IL-6 using a 
forearm cannula and an increase in muscle expression of IL-6 using a vastus lateralis biopsy, 
suggesting a systemic effect and not merely a local inflammatory response to the cannula. 
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Collectively, these considerations suggest that at least some, if not all, of the IL-6 response to a 
HFM can be credited to the meal intake, versus a mere local inflammatory response to 
cannulation. Regardless, as the majority of postprandial inflammation studies employ 
cannulation, our findings nonetheless quantify the timing and magnitude of the collective IL-6 
response to cannulation and a HFM. As IL-6 is by far the most frequently assessed marker of 
inflammation in the postprandial period, and in consideration of its varied function in the 
progression of atherosclerosis, we assert that the findings of the present analyses have relevant 
clinical and research implications. Namely, elevated IL-6 levels have been linked to multiple 
clinical considerations. IL-6 levels have been found to be significantly associated with systolic 
and diastolic blood pressure, fasting insulin, and insulin sensitivity (74). A systematic review 
found that long-term elevated IL-6 levels are associated with coronary heart disease to a similar 
degree as most traditional risk factors (75). Finally, high IL-6 levels have been associated with 
mortality in a population-based study in older adults (65). Harris et al. (65) found that the 
individuals in the highest IL-6 quartile, and therefore presenting the highest mortality risk, had 
IL-6 levels >3.19 pg/mL. Interestingly, the present review found that IL-6 starts at ~1.4 pg/mL 
and peaks at ~3 pg/mL after a HFM in healthy adults below age 60. Thus, a single HFM can 
induce a considerable postprandial increase in which circulating IL-6 levels can approach 
clinically high levels, even in young healthy individuals. While more research is needed with 
regard to the clinical importance of acute IL-6 fluctuations, considering the established 
relationship between IL-6 levels and adverse health outcomes, these acute IL-6 fluxes likely 
represent an important physiological occurrence, similar to other postprandial excursions (e.g. 
triglycerides, glucose) that have been shown to be associated with negative health outcomes. 
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Based on our search results, CRP was the second most frequently assessed (29 studies) marker of 
inflammation in the postprandial period following HFM intake. As ~80% of these studies found 
no significant change in CRP in the assessed postprandial period, and considering that the 
remaining six studies that found a significant change were divided in their findings (i.e. four 
found a significant increase and two found a significant decrease), the evidence strongly suggests 
that CRP is not a responsive marker of inflammation in the typically assessed 4-8 hour 
postprandial period in healthy adults. This assertion is in agreement with our understanding of 
the physiological pathway that results in an increase in CRP. The main drivers behind an 
increase in circulating CRP are pro-inflammatory cytokines produced locally at the site of 
damage (e.g. the inflamed endothelium). These pro-inflammatory cytokines, especially IL-6, 
then travel to the liver and stimulate increased production of acute phase response proteins, such 
as CRP and SAA (6). The time-course by which this pathway occurs is considerably slower than 
those of locally-produced cytokines, as there is typically no detectable change in the first five 
hours following a stimulus. Instead, CRP will slowly rise and peak at approximately 24 hours 
post-stimulus (Note: these responses are typically experimentally described using an endotoxin 
model, not necessarily a HFM; 12). Thus, as CRP and other acute phase response proteins reflect 
the cumulative inflammatory response (i.e. include the amplification and stimulation of many 
locally produced inflammatory molecules and their subsequent stimulation of acute phase 
response proteins in the liver), as well as bearing in mind the delayed rise and fall of acute-
response phase proteins, CRP is a particularly advantageous marker of chronic inflammation to 
assess both clinically and in research. However, for these same reasons, CRP is not a viable 
inflammatory marker to assess in the prototypical postprandial assessment study. In 
consideration of the delayed response of CRP post-stimulus, in combination with the findings of 
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the present review indicating that CRP shows no change in the vast majority of postprandial 
inflammation studies, we recommend that CRP no longer be assessed for postprandial changes in 
response to a HFM in healthy adults. To be sure, CRP retains its utility in assessing overall or 
baseline inflammatory status; however, it is simply unlikely to change in the 4-8 hours following 
ingestion of a HFM in healthy individuals younger than 60 years of age. 
TNF-α has also been widely assessed in the postprandial period as an inflammatory marker that 
is thought to typically increase following HFM intake. Specifically, TNF-α, like IL-6, is believed 
to increase quickly in the post-stimulus period, peaking at approximately 2-3 hours, then 
returning quickly to baseline (12). However, the findings of the current review disagree with this 
notion in the context of a HFM. We found that, of the studies that met the pre-established 
inclusion criteria, ~70% (19 of 28 studies) found no significant change in TNF-α following a 
HFM. Similar to CRP, the remaining studies that did find a significant change were split in terms 
of detecting a significant increase (five studies) or decrease (four studies). TNF-α is primarily 
produced by macrophages, such as those that populate inflamed regions of the vascular 
endothelium (6,76). TNF-α is known to be an important mediator in both acute and sustained 
inflammation (76). Specifically, TNF-α can induce increased secretion of itself, as well as other 
pro-inflammatory cytokines, making it an important contributor to the amplifying nature of the 
inflammatory response (76). However, while it appears that TNF-α may be particularly 
responsive in an endotoxin model of inflammation, it is not very responsive to HFM intake. As 
23 of 28 studies assessing postprandial TNF-α in the present review found either no change or a 
significant decrease following a HFM, it appears that TNF-α is either not sufficiently responsive 
to a HFM stimulus, or is too variable in its assessment, to be deemed a reliable marker of 
inflammation in the hours following HFM intake.  
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While the majority of included studies did not find a significant change in CRP or TNF-α, it is 
interesting that there was disagreement with regard to the directionality of the change in studies 
that did detect significant differences. This could possibly be driven by the composition of the 
test meal characteristics. With regard to meal composition, prior evidence suggests that type of 
fat (77), macronutrient distribution (35), and overall nutrient-density (78) of the meal can alter 
the postprandial inflammatory response. Nevertheless, there were no clear, common differences 
among studies that found an increase versus a decrease in CRP or TNF-α in the current review. 
Overall, due to the heterogeneity of study designs (especially test meal composition), this review 
is not well equipped to accurately identify the meal characteristics that induce inflammation. On 
the contrary, the goal of this review was to summarize the overall post-HFM inflammatory 
response. While there are potentially certain nuances and influential factors that likely affect the 
response, the data synthesized in the present systematic review strongly suggest that CRP and 
TNF-α do not typically change in the acute hours following HFM consumption. 
The remaining markers of inflammation assessed in the present study, IL-1β and IL-8, were 
rarely measured in the acute postprandial period in healthy individuals (IL-1β, three studies; IL-
8, four studies). Since few studies have analyzed these markers, we cannot make firm 
conclusions regarding their activity in the hours after a meal. However, our findings do not 
suggest that these markers robustly change following consumption of a HFM, as two studies 
found no change in IL-1β post-HFM and one found a significant decrease, and three studies 
found no change in IL-8 post-HFM and one found a significant increase. Despite being less-
frequently assessed, IL-1β and IL-8 are both considered pro-inflammatory cytokines that play 
adverse pathophysiological roles in CVD development, recruiting immune cells to the site of 
vascular damage, as well as promoting increased production of other pro-inflammatory cytokines 
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(79). IL-8 is produced from a variety of cells, including monocytes, macrophages, T 
lymphocytes and endothelial cells (80), whereas IL-1β is produced primarily by activated 
macrophages. Similar to TNF-α, although IL-1β and IL-8 are produced locally at the site of 
damage, they do not appear to transiently and/or robustly change in the postprandial period 
following consumption of a HFM.  
Strengths and Limitations 
There are several strengths to the present systematic review. First, we used a robust systematic 
search of 10 relevant databases with a search strategy developed with the assistance of a librarian 
(CL). The relatively large number of citations found with the original search (494 citations), in 
addition to the number of duplicate citations found by multiple databases (164 duplicates 
eliminated), suggests that the search was comprehensive and that it is unlikely that many, if any, 
relevant articles were not captured with our systematic search. Next, our generally broad, yet 
clearly defined inclusion criteria ensure that our findings are applicable to many people, namely 
healthy males and females between the ages of 18 and 60, independent of geographic region and 
body weight status. Finally, a strength of this study lies in its research and clinical utility. This 
systematic review represents the first attempt to clearly quantify the specific changes in 
commonly assessed markers of inflammation in response to a HFM.  
However, this review is not without limitations. As with any systematic review, it is possible that 
we may have missed one or more pertinent studies. In addition, not all of the studies that met our 
inclusion criteria provided all of the information needed to help answer our research question. 
While all of the authors whose papers were missing data were contacted in an effort to retrieve 
those data, and many authors complied and submitted their data to us (see Acknowledgments), 
not all responded, and consequently some studies are still missing important information, such as 
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peak and time to peak responses for an assessed cytokine. Next, the external validity of our 
findings are limited to healthy adults. Diseased individuals will typically present with a high 
systemic inflammatory tone, therefore the postprandial inflammatory response may be more 
dramatic in these populations. Additionally, it should be noted that most studies included in the 
present systematic review assessed postprandial inflammation for 4-8 hours following HFM 
intake. Thus, our review is not equipped to describe any inflammatory marker changes that could 
potentially occur outside of that typically utilized window of time. Next, an additional analysis 
regarding the relationship between the type of fat or meal in determining the postprandial 
inflammatory response would have been informative. However, due to the heterogeneity of test 
meals and the manner in which they are reported, this point was not possible for the present 
systematic review to address in a qualitative analysis. Qualitatively, though, there do not appear 
to be any noticeable trends between studies that found an increase in a marker and those that 
found no change, other than that most studies employ meals reflective of the Westernized diet: 
high in animal (saturated) fats, simple carbohydrates, processed foods, and kilocalories, and low 
in fruits, vegetables, whole grains, and fiber. Finally, a frequent consideration with postprandial 
metabolic and inflammatory response research is the use of test meals that are not necessarily 
representative of meals that individuals might consume during normal daily living. 
Consequently, this systematic review contained many studies with test meals that were quite 
large, energy-dense, and high in fat (Table 1 and Supplemental Tables 1-4). This point should be 
considered when interpreting and drawing conclusions from the present data. 
Conclusion and Future Directions 
This systematic review aimed to characterize the postprandial response of five commonly 
assessed markers of inflammation following the intake of a HFM. Our findings suggest that only 
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one of those five markers, IL-6, consistently increases in the 4-8 hours post-HFM. Specifically, 
IL-6 will, on average, start at a baseline of ~1.4 pg/mL and peak at ~2.9 pg/mL approximately 
six hours later. In relative terms, IL-6 will increase ~100% in response to a HFM. Of the 
potential independent variables considered, only percent fat in the test meal showed a significant 
(negative) correlation with the percent change in IL-6 post-HFM, although a linear regression 
model including age, BMI, percentage fat in the test meal, and energy content of the test meal 
was found to significantly predict the percent change in IL-6. With regard to CRP and TNF-α, 
these markers were found to be very commonly assessed in the postprandial period, although 
they very rarely show any change. IL-8 and IL-1β also infrequently changed following HFM 
consumption in healthy individuals, though these markers have only been assessed in a few 
studies. In light of these findings, we have several recommendations for future research: 1) we 
suggest that CRP and TNF-α no longer be assessed for postprandial changes in healthy 
individuals within the normal 6-8 hour postprandial time-course; 2) instead, there may be more 
merit in assessing other inflammatory markers, such as leukocyte-bound markers, in healthy 
individuals exposed to a HFM, as they may be more likely to display postprandial changes (12); 
3) a similar review focusing on the postprandial inflammatory response of diseased individuals is 
warranted, as the results could very likely differ from the present review that focused on healthy 
individuals; and 4) further investigation into the specific role that IL-6 plays following HFM 
intake would be beneficial.  
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ARTICLE (REF) MEAL BLOOD S/P MO FAT ENERGY N M/F AGE BMI PPP ↑↓↔ TTP FASTING PEAK QA 
     %E kcal   y kg/m2 hrs  hrs IL-6, pg/mL IL-6, pg/mL  
Arjunan et al. 2013 - South Asian (13) White bread, butter, cheese, milkshake cannula P N 57 14.3 kcal/kg 10 10M/0F 22.3 ± 1.3 25.4 ± 2.5 9 ↑ 9 1.31 ± 1.11 3.47 ± 1.43 6 
Arjunan et al. 2013 – European (13) White bread, butter, cheese, milkshake cannula P N 57 14.3 kcal/kg 10 10M/0F 23.2 ± 2.0 25.2 ± 1.6 9 ↑ 6 1.25 ± 0.80 2.65 ± 1.40 6 
Arjunan et al. 2015 - South Asian (14) White bread, butter, cheese, milkshake cannula P N 57 14.3 kcal/kg 15 15M/0F 24.0 ± 3.0 25.4 ± 3.3 9 ↑ 9 0.80 (0.50 to 1.28) 6.39 ± 6.20 6 
Arjunan et al. 2015 – European (14) White bread, butter, cheese, milkshake cannula P N 57 14.3 kcal/kg 14 14M/0F 22.0 ± 1.0 22.7 ± 2.2 9 ↑ 9 0.34 (0.21 to 0.55) 4.48 ± 4.90 6 
Bidwell et al. 2014 (15) Eggs, muffin, butter, sugary drink cannula P N 40 600 22 11M/11F 
M: 20.8 ± 0.7 
F: 21.5 ± 0.9 
M: 23.9 ± 0.9 
F: 21.1 ± 0.5 
6 ↑ NS NS NS 6 
Brandauer et al. 2013 (16) Sugar, heavy cream, chocolate syrup, powdered milk cannula P Y 84 1310 ± 34.1 10 10M/0F 27 ± 1 24.6 ± 0.7 4 ↑ 4 0.64 ± 0.39 0.97 ± .64 4.5 
Burton-Freeman et al. 2012 (17) Bagel, cream cheese, potato, milk, apple juice cannula P N 46 852 25 13M/12W 27 ± 8 22 ± 2 6 ↑ 6 NS NS 5 
Caixas et al. 2008 – lean (18) Liquid test meal cannula P Y 30 750 7 6M/1F 23.0 (21.0 - 26.0) 20.3 (18.9 - 25.1) 6 ↑ 6 0.61 (0.56 - 2.37) 3.69 ± 1.13 4 
Caixas et al. 2008 – obese (18) Liquid test meal cannula P Y 30 750 7 6M/1F 26.0 (23.0 - 27.0) 43.9 (32.8 - 48.0) 6 ↑ 6 1.75 (1.09 - 2.68) 5.04 ± 0.71 4 
Campbell et al. 2006 (19) Apple muffins, milk shake venipuncture S N 41 976 15 15M/0F 28 ± 9 NS 6 ↓ 4 1.6 ± 0.3  1.3 ± 0.3 6.5 
Delgado-Lista et al. 2011 (20) NS NS P N 60 NS 45 45M/0F NS NS 4 NS NS NS NS 3.5 
Drew et al. 2014 (21) Turkey burger, white bread cannula P N 50 600 16 16M/0F 45 ± 11 27.6 ± 5.3 6 ↑ 6 1.96 ± 1.70 3.35 ± 2.29 3.5 
Ehlers et al. 2014 (22) Hamburger, French fries cannula P N 39 1106 6 6M/0F 44.3 ± 5.2 24.8 ± 2.5 8 ↑ 6 NS NS 5 
Esser et al. 2013 (23) Milk shake (cream, sugar, water) cannula P Y 85 954 20 20M/0F 22 ± 2 22.7 ± 2.4 6 ↑ 6 0.74 ± 0.24 1.38 ± 0.73 5 
Gill et al. 2003 (24) Whipping cream, fruit, cereal, nuts, chocolate cannula P N 67 1075 8 8M/0F 27.8 ± 12.1 23.6 ± 1.0 6 ↑ 6 1.34 ± 1.16 6.93 ± 5.77 5 
Gregerson et al. 2012 (25) Cheese, eggs, oil, cream, white bread cannula P Y 77 928 15 4M/11F 44 ± 3 26.3 ± 2.0 3 ↑ 3 0.87 ± 0.12 1.13 ± 0.1 3 
Harrison et al. 2009 (26) Croissants, butter, ice cream, chocolate, potato crisps cannula S N 60 1450 8 8M/0F 26.9 ± 4.1 26.0 ± 3.6 6 ↑ 4 0.74 ± 0.45 3.13 ± 2.87 5.5 
Jimenez-Gomez et al. 2009 (27) Butter, wholemeal bread, hard-boiled egg, whole milk venipuncture P Y 60 NS 20 20M/0F NS NS 9 ↔ - NS - 6 
Johnson et al. 2016 (28) Ice cream, whipping cream cannula P N 45 1360 - 2160 12 12M/0F 23.0 ± 3.2 24.5 ± 2.7 4 ↔ - 29.8 ± 38.0 - 4 
Kiecolt-Glaser et al. 2015 (29) Eggs, turkey sausage, biscuits, gravy cannula S N 60 930 86 43M/43W 38.22 ± 8.18 32.07 ± 5.83 7 ↑ 6.5 1.76 ± 4.03 4.34 ± 3.03 4.5 
Kracmerova et al. 2014 (30) Pork meat, egg, French fries, hazelnut spread, croissant cannula P Y 47 1470 10 10M/0W 26.3 ± 1.04 23.11 ± 0.59 4 ↑ 4 0.899 ± 0.509 2.168 ± 0.44 3.5 
Lundman et al. 2007 (31) Pasta, chicken, peas, mayonaisse venipuncture P Y 60 1000 26 26M/0F 51 ± 3 26.4 ± 3.3 6 ↑ 4 3.81 ± 3.49 NS 6.5 
Madec et al. 2011 (32) Butter, bread, ham NS P Y 52 730 16 NS NS NS 6 ↔ - 0.43 ± 0.27 - 4 
Mariotti et al. 2015 (33) Milk cream, sucrose, whey protein cannula P N 70 1200 10 10M/0F 34 ± 9 30.2 ± 1.5 6 ↔ - 3.66 ± 1.46 - 3.5 
Miglio et al. 2013 (34) Fried potatoes, eggs, cheese, bread rolls cannula P Y 52 1416 15 13M/2F 45 ± 8 26.7 ± 1.9 8 ↑ 8 0.3 ± 0.3 0.97 ± 0.52 4 
Nappo et al. 2002 (35) Sausage, bread, egg, butter, olive oil venipuncture P N 59 760 20 10M/10F 44 ± 5 26.8 ± 1.2 4 ↑ 2 1.9 ± 1.0 3.1 ± 1.0 5 
Payette et al. 2009 – Men (36) Cheese, eggs, toast, butter, cream, milk, peanut butter cannula P Y 64 1600 - 2200 39 39M/0F 44.0 ± 9.1 28.9 ± 4.3 8 ↑ 8 2.40 ± 1.36 4.38 ± 2.35 5 
Payette et al. 2009 – Women (36) Cheese, eggs, toast, butter, cream, milk, peanut butter cannula P Y 64 1600 - 2200 41 0M/41F 43.7 ± 9.4 26.5 ± 5.7 8 ↑ 8 2.77 ± 1.81 5.83 ± 3.49 5 
Peluso et al. 2012 (37) Fried potatoes, eggs, cheese, bread  cannula P N 55 1344 14 12M/2W 45.1 ± 8.6 26.8 ± 2.2 8 ↑ 8 0.39 ± 0.27 1.09 ± 0.20 2.5 
Phillips et al. 2013 – Lean (38) Bacon, egg, muffin, hash browns, milk cannula P N 52 989 10 10M/0W 43.4 ± 11.3 22.8 ± 1.5 6 ↑ 6 0.9 ± 0.3 NS 6 
Phillips et al. 2013 – Obese (38) Bacon, egg, muffin, hash browns, milk cannula P N 52 989 10 10M/0W 40.9 ± 9.8 38.2 ± 6.7 6 ↑ 6 2.0 ± 1.3 NS 6 
Poppitt et al. 2008 (39) Blueberry muffin cannula S Y 71 748 18 18M/0F 23 ± 4 22.9 ± 2.0 6 ↑ 6 29.3 ± 16.8 33.4 ± 16.4 6.5 
Rankin et al. 2008 (40) Eggs, sausage, biscuit, pancake, jelly candy venipuncture S Y 53 900 17 8M/9F 26.5 ± 7.6 33.5 ± 6.7 4 ↔ - 1.5 ± 1.1 - 5.5 
Sanders et al. 2011 (41) Muffin, milkshake cannula P N 53 846 50 25M/25W 
M: 25.4 ± 4.2 
W: 24.2 ± 6.3 
M: 23.3 ± 2.1 
W: 23.7 ± 3.4 
8 ↑ 8 0.4 ± 0.1 0.9 ± 0.2 5 
Schmid et al. 2015 (42) Bread, salami, palm fat, boiled eggs cannula P Y 61 1005 21 21M/0W 41.8 ± 9.0 27.1 ± 8.2 6 ↑ 6 3.0 ± 1.1 5.1 ± 1.9 4.5 
Schwander et al. 2014 – NW (43) Bread, salami, palm fat, boiled eggs cannula S Y 61 1000 19 19M/0W 40.6 ± 9.2 23.6 ± 1.4 6 ↔ - 20.1 ± 1.7 - 4.5 
Schwander et al. 2014 – obese (43) Bread, salami, palm fat, boiled eggs cannula S Y 61 1000 17 17M/0W 44.1 ± 8.0 38.8 ± 4.9 6 ↔ - 17.9 ± 1.7 - 4.5 
Schwander et al. 2014 – NW (43) Bread, salami, palm fat, boiled eggs cannula S Y 61 1500 19 19M/0W 40.6 ± 9.2 23.6 ± 1.4 6 ↔ - 19.8 ± 1.9 - 4.5 
Schwander et al. 2014 – obese (43) Bread, salami, palm fat, boiled eggs cannula S Y 61 1500 17 17M/0W 44.1 ± 8.0 38.8 ± 4.9 6 ↑ 4 16.7 ± 1.5 21.7 ± 1.9 4.5 
Strohacker et al. 2012 (44) Sausage, egg, cheese, biscuit, hash browns cannula P N 59 1070 8 4M/4F 21 ± 3 23.1 ± 3.9 3 ↔ - 1.7 ± 0.9 - 5 
Teng et al. 2011 (45) Mashed potatoes, baked beans, milk, orange juice, lard NS S N 60 683 10 10M/0W 21.9 ± 0.7 21.0 ± 1.6 4 ↔ - 14.5 ± 1.0 - 5.5 
Tholstrup et al. 2011 (46) Mashed potatoes with fat powder NS S Y 76 620 10 0M/10F 38.2 ± 10.7 20.9 ± 1.3 6 ↓ 4 0.81 ± 0.57 0.6 ± 0.3 5 
Twickler et al. 2003 (47) Liquid cream meal NS P Y 40  NS 10 6M/4F 48.6 ± 7.7 25.4 ± 1.6 24 ↑ 10 0.9 ± 0.7 3.4 ± 2.3 4 
Volek et al. 2008 (48) Whipping cream, pudding, macadamia nuts cannula P Y 84 908 30 16M/14W 30 ± 8 24.1 ± 4.3 6 ↑ 3 0.85 ± 0.84 1.42 ± 1.36 6 
Wood et al. 2011 (49) Fast food burger, hash browns venipuncture P N 49 919 21 9M/12F 49.6 ± 4.6 24.0 ± 0.7 4 ↑ 4 0.8 ± 0.2 1.1 ± 4.4 4.5 
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Table 3-1. Details of studies that assessed pre- and post-HFM IL-6 in healthy participants. 
Forty-five studies met the inclusion criteria and assessed IL-6 before and after consumption of a 
HFM. If studies separately assessed different groups, those specific subsets are specified 
alongside the study. When applicable, data represent Mean ± SD or Mean (Range). 
Concentration values are in pg/mL. Arrows represent significant increase (↑), significant 
decrease (↓), or no significant change (↔) detected in response to the HFM.  
Abbreviations: BLOOD, method for drawing blood; BMI, body mass index; FASTING, 
baseline/fasting concentration of the marker; FAT, percentage of energy (%E) in the test meal 
from fat; M/F, ratio of males to females; MO, whether or not IL-6 was the main outcome being 
studied; N, sample size; NS, not stated; PEAK, peak or maximal observed concentration of the 
marker (“-“ if not applicable); PPP, length of postprandial period assessment in hours; S/P, 
serum or plasma; TTP, time to peak or maximal observed concentration if a significant change 
was detected (“-“ if not applicable)
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 Figures 
 
Figure 3-1. Flowchart of article search and selection process. 
Ten relevant databases were searched, yielding 494 total citations. The final number of citations 
included in the present study was 47. Please see Methods section for more details. 
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Figure 3-2. Post-HFM responses for the five assessed cytokines in healthy participants. 
These figures represent the change from the fasting or baseline concentrations to the peak or 
maximally observed concentrations for IL-6 (Panel A), CRP (Panel B), TNF-α (Panel C), IL-1β 
(Panel D), and IL-8 (Panel E). Circles represent individual studies and vertical bars represent 
mean values. For markers other than IL-6, filled circles represent studies that found a significant 
change from pre- to post-meal, and open circles represent studies that found no significant 
postprandial change (difficult to differentiate with IL-6). For IL-6, CRP, and TNF-α, data 
presented is following removal of formal outliers.  
* Significant increase in IL-6 from fasting to peak value (p < 0.05) 
Abbreviations: IL, interleukin; CRP, C-reactive protein; TNF, tumor necrosis factor. 
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Figure 3-3. Correlations of several study variables with percent change in IL-6 from pre- to 
post-HFM in healthy participants. 
The percent change in IL-6 from baseline to the peak or maximal observed response 
concentration was assessed for potential correlations with the percent of energy from fat in the 
test meal (Panel A), the energy content (in kcal) of the test meal (Panel B), the mean BMI of the 
study participants, and the mean age of the study participants. The only variable that was found 
to have a significant correlation with percent change in IL-6 was percentage fat in the test meal, 
which exhibited a moderate negative correlation. 
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Chapter 4 - Realistic Test-Meal Protocols Lead to Blunted 
Postprandial Lipemia but Similar Inflammatory Responses 
Compared to a Standard High-fat Meal 
 Abstract 
INTRODUCTION: A substantial rise in triglycerides following a meal is associated with 
increased risk for cardiovascular disease. Most studies investigating the effects of a meal on 
triglycerides have not utilized meals that reflect typical consumption. The objective of this study 
was to compare the triglyceride and inflammatory responses of true-to-life meals, containing 
moderate fat and energy content, with a high-fat, high-energy, low-carbohydrate meal (HFM) 
typically used to test triglyceride responses. METHODS: Nine healthy, insufficiently active men 
(age: 25.1 ± 6.7 years; BMI: 25.8 ± 7.0 kg/m2; <150 min/week moderate- to vigorous-intensity 
physical activity) completed three meal trials in random order: a HFM (17 kcal/kg, 60% fat); a 
moderate-fat meal (MFM; 8.5 kcal/kg, 30% fat); and a biphasic meal (BPM), in which 
participants consumed the full MFM at baseline and three hours post-meal. Blood samples were 
collected via indwelling catheter at baseline and hourly for six hours. RESULTS: Peak blood 
triglycerides were significantly greater (p = 0.003) following the HFM (285.2 ± 169.7 mg/dL) 
compared to the MFM (156.0 ± 98.7 mg/dL), but the BPM (198.3 ± 182.8 mg/dL) was not 
significantly different from the HFM (p = 0.06) or the MFM (p = 0.99). Total area under the 
curve (AUC) for triglycerides was greater following the HFM (1348.8 ± 783.7 mg/dL x 6 hrs) 
compared to the MFM (765.8 ± 486.8 mg/dL x 6 hrs; p = 0.0005) and the BPM (951.8 ± 787.7 
mg/dL x 6 hrs; p = 0.03), although the MFM and BPM were not significantly different (p = 
0.72). There was a significant time-by-meal interaction for interferon-γ, but not for interleukins-
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6, 8, or 10. CONCLUSIONS: These findings in insufficiently active healthy young men suggest 
that the large triglyceride response following HFMs in previous studies may not reflect the 
metabolic state of many individuals in daily life. 
 Introduction 
Cardiovascular disease (CVD) represents a serious risk and burden for many adults in western 
society (1). Previous research has linked increased CVD risk to both low levels of physical 
activity (2) and poor dietary habits (3). Specifically, there is evidence implicating consumption 
of single high-fat meals (HFMs) in elevating CVD risk. An exaggerated postprandial triglyceride 
(TG) response, termed postprandial lipemia, has been linked to a high risk for CVD (4). 
Mechanisms connecting HFM consumption to CVD risk are numerous, and include 
subendothelial penetration of lipoproteins, increased oxidative stress, and impaired endothelial 
function (5). In particular, there is evidence that inflammation may increase acutely following a 
HFM, suggesting the potential activation of an inflammatory cascade after intake of only one 
meal (6). As inflammation is an important hallmark of CVD (7), inflammation provides a 
potentially important connection between HFM intake and CVD risk. 
However, there are several important methodological considerations when interpreting the 
results of previous postprandial studies. First, many studies utilize test meals that are quite large, 
calorie-dense, and rich in fat, such as ~1300 kcal and 60% fat (8,9,10,11,12,13,14,15). 
Additionally, the standard practice in postprandial studies is to have participants come into the 
lab fasted, eat the large meal, and then not eat again for 6-8 hours while their post-meal response 
is monitored. These design features are understandable from a scientific stand-point, but do not 
necessarily lend themselves well to understanding the actual post-meal challenges that many 
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individuals face on a daily basis, as they do not represent typical eating patterns (16). More 
research into the postprandial response under true-to-life scenarios is warranted. 
The purpose of this study was to compare metabolic and inflammatory responses to three 
different meal conditions, in order to better understand the metabolic and inflammatory 
challenges faced by the body on a daily basis. We utilized a high-fat meal, representative of 
meals used in previous postprandial studies, as well as a moderate-fat meal, and a third condition 
in which participants consumed the full moderate-fat meal twice, three hours apart (biphasic 
meal). We hypothesized that: 1) the high-fat meal would elicit a significantly greater TG 
response compared to the moderate-fat meal and biphasic meal; and 2) there would be a greater 
inflammatory response following the high-fat meal compared to the other two meals. 
 Methods 
Participants 
Nine young men (age 18-35) were recruited to participate in the present study. Participants were 
not regularly engaging in exercise (<30 minutes/week) and were not meeting physical activity 
guidelines (<150 minutes/week of moderate- to vigorous-intensity physical activity; 17), 
according to self-report via International Physical Activity Questionnaire. Participants were free 
of any ongoing chronic disease, as confirmed via medical history questionnaire. This study was 
approved by the Institutional Review Board at Kansas State University. 
Overall Study Design 
The present study was a randomized crossover design. Participants reported to the laboratory on 
four separate occasions. The first session was for an initial assessment, in which participants 
completed paperwork and anthropometric tests were conducted. Participants completed an 
informed consent, medical history questionnaire, and the physical activity questionnaire. Blood 
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pressure was assessed at rest using an automated blood pressure cuff (Omron International, 
Shiokoji Horikawa, Japan). Height was measured using a portable stadiometer (Invictus Plastics, 
Leicaster, England) and weight was assessed via digital scale (Pelsar LLC, Alsip, IL, USA). 
Body composition was then measured via dual-energy X-ray absorptiometry (DEXA) scan (GE 
Lunar Prodigy, Madison, WI, USA). For the three main assessments, participants consumed one 
of three test meals in randomized order: a standard high-fat meal (HFM), a moderate-fat meal 
(MFM), and a biphasic meal (BPM), in which participants consumed the MFM twice, separated 
by a period of three hours. Blood draws were made at baseline and serially (each hour) for six 
hours to assess the postprandial metabolic and inflammatory responses. Each meal trial was 
separated by at least one week and no more than three weeks. A wash-out period of at least one 
week was chosen to eliminate the possibility of a carry-over effect. As previous studies suggest 
that postprandial TG will return to baseline levels within 8-10 hours post-HFM (18,19), our 
seven-day wash-out period ensures the observance of independent meal effects. 
Test Meals 
Three test meals were used in the present study: 1) a HFM (17 kcal/kg body mass; 64% fat (21% 
saturated fat), 16% CHO, 20% protein; 3 g fiber/serving; energy density: 2.0 kcal/g) that 
consisted of potatoes, eggs, sausage, and cheddar cheese; 2) a MFM (8.5 kcal/kg body mass; 
30% fat (13% saturated fat), 55% CHO, 15% protein; 2 g fiber/serving; energy density: 2.1 
kcal/g) comprised of sausage, egg, cheese, and whole grain crust; and 3) a BPM in which the full 
MFM was consumed twice, three hours apart. The HFM trial was designed to be representative 
of typical meals used in previous postprandial lipemia studies (8,9,10,11,12,13,14,15). The MFM 
was designed to be half the kcal of the HFM, while presenting primarily the same contents (i.e. 
sausage, egg, cheese). In the BPM trial, we wanted to assess the potential compounding effects 
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of smaller, more moderate meals, as it is reasonable for a person to eat twice in a six-hour period. 
In total, the BPM was equal in kcal to the HFM trial. When accounting for participant body 
mass, the HFM contained 1319 ± 338 kcal and the MFM contained 660 ± 169 kcal. 
Meal Test Protocol 
Prior to the first meal trial (HFM, MFM, or BPM), which was determined via randomization for 
each participant, the participants were instructed to record their dietary habits for three full days. 
For the remaining two trials, participants were given a photocopy of their diet record from the 
first meal trial, which they were instructed to repeat. Participants were instructed to refrain from 
planned exercise for two full days prior to each meal trial. Participants also abstained from 
alcohol and caffeine for twelve hours prior to each assessment. For each session, participants 
were given a hard copy reminder sheet of these instructions, and no participants reported an 
impactful deviation from these instructions at any point throughout the study. 
On each meal trial day, participants reported to the lab following a 10-hour overnight fast. An 
indwelling safelet catheter was inserted into a forearm vein via 24-gauge needle (Exelint 
International, Redondo Beach, CA, USA). The IV catheter was kept patent with a steady infusion 
of 0.9% NaCl solution (~1 drip/second) and fixed in place via placement of tegaderm film (3M 
Healthcare, Neuss, Germany). When the IV was in place, a baseline blood draw was performed. 
For each blood draw, a 3 mL syringe (BD, Franklin Lakes, NJ, USA) was used to clear the line 
of saline, after which a 5 mL syringe (BD, Franklin Lakes, NJ, USA) was used for the actual 
blood sample. Blood draws were used to assess whole blood TG, glucose, total cholesterol 
(Total-C), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol 
(LDL-C), and markers of inflammation (see Analytical Procedures section). After the 
baseline/fasting blood draw, participants would eat the respective meal in 20 minutes or less. 
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Water was available to participants ad libitum with each meal and throughout the post-meal 
period. Participants remained in the laboratory for six hours after the completion of each meal; 
the time started following the last bite of the meal. Blood draws were performed hourly for six 
hours after the meal. Metabolic markers were assessed every hour, while inflammatory markers 
were assessed at baseline and three and six hours post-meal. Markers of inflammation were 
assessed less frequently than metabolic markers primarily due to funding limitations. 
Inflammatory assessments were evenly spaced (baseline, three and six hours post-meal) to best 
characterize the postprandial inflammatory response given available resources. 
Analytical Procedures 
Whole blood metabolic measures (TG, glucose, Total-C, HDL-C, and LDL-C) were determined 
via Cholestech LDX analyzer (Alere Cholestech, San Diego, CA, USA). For each sample, 
several drops of whole blood were drawn into a capillary tube and plunged into a Cholestech 
LDX Lipid+Glu cassette (Alere Cholestech, San Diego, CA, USA). The cassette was then 
inserted into the Cholestech LDX analyzer for processing. The remaining blood sample was then 
centrifuged for 12 minutes and the plasma was pipetted into 0.6 mL snap-cap containers (Fisher, 
Hanover Park, IL, USA). Plasma was stored at -60 degrees Celsius until study completion. At the 
conclusion of the study data collection, plasma samples were analyzed in duplicate via custom 
high-sensitivity T-cell bead-based 4-plex assay (Eve Technologies, Calgary, Canada). The 
multiplex assay was conducted at Eve Technologies via the Bio-Plex 200 system (Bio-Rad 
Laboratories, Inc., Hercules, CA, USA), and a Milliplex high-sensitivity custom human cytokine 
kit (Millipore, St. Charles, MO, USA) according to protocol specifications. The four markers of 
inflammation assessed in the present study were interleukin (IL)-6, IL-8, IL-10, and interferon 
(IFN)-γ. Coefficients of variation were less than 10% for all inflammatory marker analyses. 
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Statistical Analyses 
An a priori sample size calculation (α = 0.05; power = 0.80) elucidated that six participants 
would be needed to detect differences between meals in the postprandial TG total area under the 
curve (AUC-tot) response. However, nine participants were recruited to increase power to detect 
differences in other outcomes, such as markers of inflammation (although an a priori sample size 
calculation was not conducted for inflammatory markers). AUC-tot, incremental area under the 
curve (AUC-inc), peak value, and time to peak value were determined for each of the metabolic 
and inflammatory markers in each meal trial. The data were checked for normality using the 
Shapiro-Wilk formal normality test. If the data were normal, a one-way analysis of variance 
(ANOVA) was conducted to test for differences between meals. If the data were non-normal, a 
non-parametric Friedman test was utilized to test for meal differences. Time-course changes in 
metabolic and inflammatory markers in response to each meal were determined via two-way 
(meal x time) repeated measures ANOVA with a Tukey’s adjustment for post hoc pairwise 
comparisons. A type 1 error rate of 0.05 was allowed for all analyses in determining significant 
differences. 
 Results 
Participant characteristics are presented in Table 1. Three participants reported with systolic 
blood pressure >120 mmHg. No participants were found to have high diastolic blood pressure. 
With regard to BMI, five participants were normal-weight (18.5-24.9 kg/m2), two participants 
were over-weight (25.0-29.9 kg/m2), and two participants were obese (≥30 kg/m2; 20). Two 
participants presented with fasting TG greater than 150 mg/dL. All fasting glucose values were 
below 110 mg/dL. No participants were found to have high fasting Total-C (>200 mg/dL). There 
were no differences between meals with regard to fasting metabolic markers (p’s > 0.05). 
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Postprandial metabolic data are presented in Table 2. There were significant meal effects with 
regard to TG peak, time to peak, AUC-tot, and AUC-inc. A significantly higher TG peak was 
observed in the HFM compared to the MFM (p = 0.003), but there were no differences between 
the BPM and the HFM (p = 0.06) or MFM (p = 0.99). The time to peak TG response was 
significantly longer in the HFM (p = 0.01) and BPM (p = 0.01) trials compared to the MFM trial, 
with no difference (p = 0.29) between HFM and BPM. The AUC-tot response for TG was 
significantly larger in the HFM compared to the BPM (p = 0.03) and MFM (p = 0.0005), but 
there was no difference in the BPM compared to the MFM (p = 0.72). Similarly, AUC-inc was 
greater in the HFM versus the BPM (p = 0.01) and MFM (p = 0.001), while there was no 
difference in the BPM compared to the MFM (p = 0.99). Figure 1A displays TG time-course for 
responses during each trial.  
There were no significant meal effects with regard to glucose (Table 2). Time-course responses 
for glucose are displayed in Figure 1B. Overall, there were no substantial differences between 
the three meal trials in terms of the glucose response. 
Metabolic Load Index (MLI) is determined by adding circulating glucose and TG in order to 
better characterize the metabolic challenge faced by the body, in comparison to looking at 
glucose and TG separately (5). There was a significant meal effect for MLI across trials in terms 
of peak, time to peak, AUC-tot, and AUC-inc (Table 2). Within pairwise comparisons, the HFM 
elicited a greater peak compared to the MFM (p = 0.007) and BPM (p = 0.03) trials, with no 
difference between MFM and BPM (p = 0.99). Time to peak MLI response was significantly 
longer in the BPM condition compared to the MFM condition (p = 0.048), but the HFM was not 
significantly different from the MFM (p = 0.06) or BPM (p = 0.09). With regard to AUC-tot, the 
HFM elicited a greater MLI response compared to the MFM (p = 0.003), but not the BPM (p = 
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0.06); no difference was detected in AUC-tot in the MFM versus BPM (p = 0.99). The HFM 
produced a greater AUC-inc MLI response compared to the MFM (p = 0.003) and BPM (p = 
0.02), and no difference existed between the MFM and BPM (p = 0.52). Figure 1C displays 
time-course changes for MLI in the postprandial period in response to the three meals.  
There were no significant meal effects with regard to Total-C. However, significant meal effects 
were determined for LDL-C peak and AUC-tot responses. The peak LDL-C response was 
significantly greater in the MFM condition compared to the HFM (p = 0.007) and BPM (p = 
0.007) conditions, although there was no difference between HFM and BPM (p = 0.77). With 
regard to AUC-tot, the LDL-C response was significantly larger in the MFM trial versus the 
HFM (p = 0.0009) and BPM (p = 0.004) trials, with no difference between the HFM and BPM 
conditions (p = 0.46). A significant meal effect was detected with regard to the HDL-C AUC-tot 
response. The MFM elicited a significantly greater HDL-C AUC-tot response when compared to 
the HFM (p = 0.02) and the BPM (p = 0.047), but there was no difference between the HFM and 
BPM (p = 0.86). The postprandial time-course for responses generally revealed a steady increase 
in HDL-C following the MFM, while HDL-C tended to decrease after the HFM (Figure 1D).  
Table 3 displays fasting and postprandial values for four markers of inflammation assessed at 
baseline and three and six hours post-meal: IL-6, IL-8, IL-10, and IFN-γ. A significant meal 
effect was detected for IFN-γ AUC-inc. However, within this meal effect, there were no 
significant post-hoc pairwise comparisons. No other meal effects were detected for other 
inflammatory markers with regard to fasting, peak, time to peak, AUC-tot, or AUC-inc values. 
There was no significant time x treatment interaction for IL-6 (p = 0.19), IL-8 (p = 0.06), or IL-
10 (p = 0.16). However, there was a significant time x treatment interaction for IFN-γ (p = 0.01). 
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In post-hoc pairwise comparisons, IFN-γ was significantly higher (p = 0.02) in the BPM 
compared to the HFM three hours post-meal. 
 Discussion 
Main Findings 
The purpose of the present study was to compare metabolic and inflammatory responses to three 
different meal conditions, with the intention of better assessing the metabolic and inflammatory 
challenges faced by the body under real life circumstances. The main finding of the present study 
was that overall the HFM elicited a substantially greater TG response compared to the other two 
meal trials. This finding suggests that the single large bolus of fatty food, representative of meals 
used in previous postprandial studies, may induce a very different TG response compared to 
more reasonable meals (i.e., fewer kcal, less fat, divided into smaller meals over time) consumed 
in daily living. We also hypothesized that the HFM would elicit a greater inflammatory response 
compared to the MFM and BPM. However, this prediction was only partially supported. With 
the exception of a significant time x meal interaction for IFN-γ, there were no real appreciable 
differences between meal trials with regard to markers of inflammation. 
Postprandial TG Response 
We found that, relative to the standard HFM, a meal more moderate in terms of kcal and percent 
fat (i.e. the MFM) induced a blunted postprandial TG response. However, it should be noted that 
the MFM contained 660 ± 169 kcal – a relatively substantial meal. The MFM also contained 
generally the same ingredients (sausage, egg, cheese) as the HFM. Thus, the MFM, arguably 
representative of a reasonable meal consumed in daily living induced a blunted change in TG 
over the six-hour time-course, while the HFM produced a large, sustained TG response. It has 
been reported that elevated postprandial TG can independently increase myocardial infarction 
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risk by 40% per 100 mg/dL increase in TG (21,22). Since, on average, the HFM elicited a peak 
TG response >100 mg/dL greater than the MFM, it is very likely that the differences seen 
between meals with regard to postprandial lipemia have clinical significance.  
For the first three hours post-meal, the TG responses of the BPM mimicked the MFM; however, 
after the consumption of the second meal at hour three, a compounding effect was observed, and 
the TG values for the BPM were significantly greater than the MFM at four, five and six hours 
post-meal. These findings support the notion that postprandial lipemic responses can be 
summative, impacted by both the lingering TG levels of prior meals and the TG flux of a more 
recent meal. This conclusion is important to consider, as many postprandial studies only feature 
one meal followed by a prolonged period of assessment in which no additional snacks or meals 
are consumed. Thus, future research should further assess multiple meals in attempting to 
characterize the TG flux under normal dietary consumption and timing.  
To our knowledge, only one previous study has investigated postprandial lipemia in the context 
of multiple sequential meals. Pfeiffer et al. (23) assessed postprandial lipemia in response to two 
meals that each provided ~1/3 of each participant’s daily energy needs and were 33% fat. 
However, the purpose of the study was to determine the minimum amount of walking required to 
blunt postprandial lipemia to the sequential meals. Thus, no comparison was made between the 
moderate, sequential meals to a standard HFM, as was done in the present study. Our results 
support the concept of summative TG responses to sequential meals, but we also found that the 
HFM elicited a significantly greater postprandial lipemia AUC response compared to the BPM, 
even though the BPM contained the same amount of kcals. This finding could point to one or 
several considerations: 1) the 6-hour postprandial duration may not have been sufficient to 
witness the entire BPM lipemic response; 2) the HFM may overwhelm the metabolic clearing 
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capacity of the body to a greater degree than the BPM; and 3) the difference between the HFM 
and BPM may simply be due to the different proportional fat contents. More research is needed 
to elucidate the potential response differences between two small meals versus one very large 
meal. 
Postprandial HDL-C Response 
An important finding in the present study was the divergent postprandial responses with regard 
to HDL-C. There were no differences in HDL-C between meals at baseline, but over the course 
of the 6-hour post-meal period, HDL-C tended to decrease in the HFM trial but remain steady in 
the MFM trial. There were also main meal effects with regard to HDL-C peak and AUC-tot. 
Clearly, these different meal trials produced different effects on HDL-C. Prior evidence has 
shown that the response of HDL-C is inversely related to the magnitude of postprandial lipemia 
(13) and it has been speculated that the lowering of HDL-C in response to HFM consumption 
can be an avenue by which HFMs induce deleterious cardiovascular effects (24). 
Markers of Inflammation 
To our knowledge, the present study is the first to investigate inflammatory responses to a HFM 
as compared to more moderate meals, including sequential moderate meals. Investigating the 
inflammatory responses to these moderate meals is important, as inflammation has been 
mechanistically linked to the development and progression of CVD. In our cohort of young, 
insufficiently active men, with the exception of IFN-γ AUC-inc, there were no main postprandial 
effects seen across meals among the markers of inflammation. Further, only IFN-γ exhibited a 
significant time x meal interaction in the postprandial period. 
IFN-γ is an important cytokine released from activated macrophages and is an influential player 
in the inflammatory cascade that promotes atherosclerosis (25). IFN-γ has been minimally 
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assessed in the post-meal period, but has been shown to increase in one study utilizing a very 
large HFM (26). In our study employing meals of varying fat and energy content, despite a 
significant time x meal interaction, there were no clear and consistent postprandial differences 
between the three meal trials, although BPM was significantly greater than HFM three hours 
post-meal. 
IL-6 is an intriguing inflammatory marker, as it is both a cytokine and a myokine, and there is 
ongoing debate as to whether it is pro- or anti-inflammatory in nature. Across studies, there is 
fairly consistent evidence that IL-6 increases in response to HFM intake (27,28). Whether or not 
this rise in IL-6 is beneficial or deleterious remains to be determined. Interestingly, there was not 
a significant meal x time interaction for IL-6 in the postprandial period. The reason for the lack 
of change in IL-6 in the present study, particularly after the HFM, is unclear. 
Strengths and Experimental Considerations 
In our view, this study has several points of strength. First, this investigation was designed to be 
true to life and provide valuable data regarding the postprandial metabolic and inflammatory 
challenges experienced by individuals on a daily basis. The HFM was very large, energy-dense, 
and rich in fat, similar to previous studies (8,9,10,11,12,13,14,15), while the BPM and MFM 
were moderate and reflective of more typical dietary behavior (16). Thus, the results of the 
present study are likely to reflect the postprandial circumstances for many individuals in daily 
life. Next, this study utilized a randomized cross-over design, eliminating the possibility of 
systematic participant differences confounding the effects detected from the three meal trials. 
Lastly, within our cohort, variability existed with regard to body composition, fasting metabolic 
levels, and age. Nevertheless, we detected visible differences between the meals, thus increasing 
the generalizability of the present study. 
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However, several experimental considerations do need to be made when interpreting our 
findings. Our findings cannot necessarily be extrapolated to women, older adults, physically 
active individuals, and diseased populations, as each of these groups has been demonstrated to 
display different postprandial lipemic responses relative to young healthy men. Also, it would 
have been potentially useful to have included a fourth trial in which the HFM was divided and 
delivered biphasically, similar to the BPM. From a study design perspective, that point is logical. 
However, the present study was intentionally designed to compare a HFM representative of those 
used in the literature to two other meal trials that were more realistic in nature with regard to size 
and timing. Delivering the HFM biphasically would have nonetheless resulted in participants 
eating two meals that were >60% fat, and therefore shed light on whether or not TG differences 
between meal conditions in the present study were simply due to differences in fat content. Next, 
while participants were continually reminded of the necessary lifestyle controls leading up to 
each meal trial (avoidance of exercise and caffeine, replication of diet), adherence to these 
instructions was not formally documented, representing a potential limitation of the present 
study. Finally, due to cost, markers of inflammation were assessed three and six hours post-meal, 
as opposed to hourly in the case of metabolic markers. Consequently, our data are not equipped 
to characterize the postprandial response curve of these inflammatory markers with high 
precision. 
Conclusion 
The purpose of this investigation was to compare metabolic and inflammatory responses to three 
meal conditions, in order to better define and understand the metabolic and inflammatory 
challenges that individuals experience in daily life. The main finding was that the HFM induced 
a considerably greater TG response compared to the other realistic meal protocols, signifying 
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that a single large intake of energy-dense high-fat food, representative of meals used in previous 
postprandial studies, may result in a markedly different lipemic response compared to smaller, 
moderate-fat meals consumed in daily living. However, we found few clear and noteworthy 
differences between meal trials with regard to markers of inflammation. We encourage future 
research to assess the true-to-life postprandial metabolic and inflammatory responses in other 
relevant populations that are much less represented in the current literature: women, older adults, 
and diseased populations. In doing so, we can gain a better understanding of the metabolic and 
inflammatory challenges faced by individuals on a daily basis.
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 Tables 
    Mean ± SD 
Age (years)  25.1 ± 6.8 
Height (cm)  173.5 ± 6.1 
Mass (kg)  77.6 ± 19.9 
Body mass index (kg/m2)  25.8 ± 7.0 
Body fat (%)  20.5 ± 11.9 
Trunk fat (%)  26.5 ± 14.0 
Fasting TG (mg/dL)  109.9 ± 65.0 
Fasting glucose (mg/dL)  88.0 ± 8.0 
Fasting total cholesterol (mg/dL)  146.0 ± 20.8 
Fasting LDL-C (mg/dL)  90.5 ± 20.3 
Fasting HDL-C (mg/dL)  35.7 ± 7.3 
 
Table 4-1. Participant characteristics. 
Data are Mean ± SD. 
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  HFM MFM BPM p-value 
Triglycerides     
Peak (mg/dL) 214.0 (154.5-415.5)a 113.0 (85.0-221.0)b 129.0 (103.5-228.5)ab 0.0013 
Time to peak (hours) 3.8 ± 1.3a 2.4 ± 1.4b 4.4 ± 1.0a 0.0017 
AUC-tot (mg/dL x 6 hr) 1087.0 (769.5-1957.5)a 546.0 (411.3-1150.3)b 645.0 (514.0-1213.3)b <0.0001 
AUC-inc (mg/dL x 6 hr) 439.0 (360.8-939.0)a 167.0 (66.1-313.8)b 153.0 (111.7-381.5)b 0.0002 
Glucose     
Peak (mg/dL) 98.0 (94.5-105.0) 102.0 (93.0-136.5) 110.0 (91.5-120.0) 0.99 
Time to peak (hours) 1.0 (0.5-3.5) 1.0 (1.0-2.0) 1.0 (1.0-5.0) 0.30 
AUC-tot (mg/dL x 6 hr) 531.2 ± 51.3 528.2 ± 55.8 543.0 ± 72.3 0.72 
AUC-inc (mg/dL x 6 hr) -4.0 ± 44.2 12.2 ± 70.5 12.2 ± 60.1 0.70 
Metabolic Load Index     
Peak (mg/dL) 306.0 (240.5-510.5)a 223.0 (188.5-314.5)b 214.0 (194.0-331.5)b 0.0030 
Time to peak (hours) 3.4 ± 1.1ab 2.2 ± 1.6a 4.3 ± 1.6b 0.01 
AUC-tot (mg/dL x 6 hr) 1607.0 (1299.0-2558.0)a  1046.0 (919.8-1714.5)b 1130.0 (1028.3-1798.0)ab 0.0013 
AUC-inc (mg/dL x 6 hr) 648.7 ± 394.5a 257.2 ± 198.2b 316.4 ± 327.0b  0.001 
Total Cholesterol     
Peak (mg/dL) 152.1 ± 21.8 165.3 ± 20.0 148.9 ± 22.4 0.07 
Time to peak (hours) 2.9 ± 2.1 4.1 ± 2.2 1.6 ± 1.8 0.06 
AUC-tot (mg/dL x 6 hr) 856.2 ± 125.6 914.7 ± 99.4 822.6 ± 121.4 0.08 
AUC-inc (mg/dL x 6 hr) -3.0 (-25.6-34.4) -38.0 (-69.0-27.7) -53.1 (-100.8-31.3) 0.40 
LDL-Cholesterol     
Peak (mg/dL) 86.3 ± 21.4a 104.0 ± 19.9b 85.1 ± 23.9a 0.0004 
Time to peak (hours) 0.0 (0.0-1.0) 3.0 (0.0-5.5) 1.0 (0.0-2.0) 0.19 
AUC-tot (mg/dL x 6 hr) 360.8 ± 198.2a 539.8 ± 130.5b 396.1 ± 162.0a 0.0013 
AUC-inc (mg/dL x 6 hr) -68.3 ± 41.7 -28.2 ± 92.9 -47.4 ± 45.0 0.39 
HDL-Cholesterol     
Peak (mg/dL) 36.8 ± 8.5 43.3 ± 6.3 37.3 ± 7.6 0.02 
Time to peak (hours) 1.0 (0.0-3.0) 5.0 (0.0-6.0) 0.0 (0.0-1.5) 0.12 
AUC-tot (mg/dL x 6 hr) 191.7 ± 53.4a 224.8 ± 44.1b 194.3 ± 53.4a 0.03 
AUC-inc (mg/dL x 6 hr) -15.7 ± 18.6 -0.4 ± 25.4 -10.8 ± 20.8 0.35 
 
Table 4-2. Postprandial metabolic data for the three meal trials (HFM, MFM, BPM) in 
insufficiently active healthy young men. 
All metabolic markers were measured in whole blood. Normally distributed data are presented as 
Mean ± SD and non-normally distributed data are presented as Median (Interquartile Range), n = 
9. The p-value column represents main effects between meals. Labeled means in a row without a 
common letter differ, p < 0.05. See Results section for pairwise comparison p-values. 
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HFM, high-fat meal; MFM, moderate-fat meal; BPM, biphasic meal; AUC-tot, total area under 
the curve; AUC-inc, incremental area under the curve; LDL, low-density lipoprotein; HDL, 
high-density lipoprotein 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
103 
 
  HFM MFM BPM   p-value 
IL-6      
Fasting (pg/mL) 1.41 ± 0.65 1.64 ± 1.13 1.66 ± 0.86  0.53 
Peak (pg/mL) 1.75 ± 0.75 2.18 ± 1.04 1.83 ± 0.82  0.26 
Time to peak (hours) 6.0 (1.5-6.0) 6.0 (1.5-6.0) 1.5 (0.0-5.3)  0.12 
AUC-tot (pg/mL x 6 hr) 3.08 ± 1.09 3.98 ± 2.47 3.78 ± 2.00  0.79 
AUC-inc (pg/mL x 6 hr) -0.10 (-0.48-0.63) -0.10 (-0.75-0.45) -0.18 (-0.41-0.10)  0.97 
IL-8      
Fasting (pg/mL) 6.29 ± 1.09 6.38 ± 1.12 6.13 ± 0.93  0.13 
Peak (pg/mL) 6.73 ± 1.04 6.43 ± 1.12 6.33 ± 1.02  0.12 
Time to peak (hours) 2.6 ± 3.0 0.8 ± 1.4 2.6 ± 2.5  0.18 
AUC-tot (pg/mL x 6 hr) 12.31 ± 2.14 12.20 ± 2.47 11.96 ± 1.96  0.24 
AUC-inc (pg/mL x 6 hr) -0.27 ± 0.79 -0.56 ± 0.59 -0.30 ± 0.63  0.47 
IL-10      
Fasting (pg/mL) 4.28 ± 2.16 4.01 ± 1.91 4.27 ± 1.79  0.42 
Peak (pg/mL) 4.87 ± 2.54 4.20 ± 1.83 4.42 ± 1.85  0.18 
Time to peak (hours) 4.5 (0.8-6.0) 0.0 (0.0-3.0) 1.5 (0.0-5.3)  0.27 
AUC-tot (pg/mL x 6 hr) 26.48 ± 14.70 22.98 ± 10.48 23.86 ± 10.93  0.18 
AUC-inc (pg/mL x 6 hr) 1.17 ± 3.28 -0.73 ± 2.01 -1.37 ± 2.32  0.12 
IFN-γ      
Fasting (pg/mL) 15.73 ± 4.71 14.75 ± 4.11 14.59 ± 5.42  0.26 
Peak (pg/mL) 15.75 ± 4.64 15.32 ± 4.05 15.07 ± 4.91  0.45 
Time to peak (hours) 0.0 (0.0-0.0) 0.0 (0.0-3.0) 1.5 (0.0-3.0)  0.56 
AUC-tot (pg/mL x 6 hr) 81.08 ± 25.62 83.64 ± 24.49 84.04 ± 27.33  0.56 
AUC-inc (pg/mL x 6 hr) -13.28 ± 5.99 -4.88 ± 8.66 -3.50 ± 7.74  0.046 
 
Table 4-3. Postprandial inflammatory data for the three meal trials (HFM, MFM, BPM) in 
insufficiently active healthy young men. 
All inflammatory markers were measured in plasma. Normally distributed data are presented as 
Mean ± SD and non-normally distributed data are presented as Median (Interquartile Range), n = 
9. The p-value column represents main effects between meals.  
HFM, high-fat meal; MFM, moderate-fat meal; BPM, biphasic meal; AUC-tot, total area under 
the curve; AUC-inc, incremental area under the curve; IL, interleukin; IFN, interferon. 
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 Figures 
 
Figure 4-1. Postprandial metabolic responses following the three meal trials (HFM, MFM, 
BPM) in insufficiently active healthy young men. 
Metabolic markers in whole blood, including TG (Panel A), glucose (Panel B), MLI (Panel C), 
and HDL-C (Panel D) were assessed at baseline (time 0) and serially for six hours after each 
meal trial (HFM, MFM, and BPM). Data are Mean ± SEM, n = 9. 
* HFM vs MFM; ^ HFM vs BPM; + MFM vs BPM  
HFM, high-fat meal; MFM, moderate-fat meal; BPM, biphasic meal; HDL-C, high-density 
lipoprotein cholesterol 
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Figure 4-2. Postprandial inflammatory responses following the three meal trials (HFM, 
MFM, BPM) in insufficiently active healthy young men. 
Plasma inflammatory markers, including IL-6 (Panel A), IL-8 (Panel B), IL-10 (Panel C), and 
IFN-γ (Panel D) were assessed at baseline (time 0) and three and six hours after each meal trial 
(HFM, MFM, and BPM). Data are Mean ± SEM, n = 9. 
^ HFM vs BPM 
HFM, high-fat meal; MFM, moderate-fat meal; BPM, biphasic meal; IL, interleukin; IFN, 
interferon 
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Chapter 5 - Postprandial Metabolic Responses Differ by Age Group 
and Physical Activity Level 
 Abstract 
Objectives: To compare the postprandial metabolic responses to a high-fat meal in healthy adults 
who differ by age and physical activity level. 
Design: Cross-sectional, quasi-experimental design 
Setting: Physical Activity and Nutrition Clinical Research Consortium (PAN-CRC) at Kansas 
State University (Manhattan, KS, USA) 
Participants: Twenty-two healthy adults: 8 younger active (YA) adults (4M/4W; 25 ± 5 yr), 8 
older active (OA) adults (4M/4W; 67 ± 5 yr), and 6 older inactive (OI) adults (3M/3W; 68 ± 7 
yr).  
Intervention: Following an overnight (10-hour) fast and having abstained from exercise for 2 
days, participants consumed a high-fat meal (63% fat, 34% CHO; 12 kcal/kg body mass; 927 ± 
154 kcal). To assess the metabolic response, blood draws were performed at baseline and each 
hour following the meal for 6 hours. 
Measurements: Fasting and postprandial triglycerides (TG), glucose, Total-C, and HDL-C were 
measured. Metabolic load index (MLI) and LDL-C were calculated. 
Results: There were significant group x time interactions for TG (p < 0.0001) and MLI (p = 
0.004). The TG total area-under-the-curve (tAUC) response was significantly lower in YA 
(407.9 ± 115.1 mg/dL x 6 hr) compared to OA (625.6 ± 169.0 mg/dL x 6 hr; p = 0.02) and OI 
(961.2 ± 363.6 mg/dL x 6 hr; p = 0.0002), while the OA group TG tAUC was lower than the OI 
group (p = 0.02). The TG peak was significantly lower in YA (90.5 ± 27.0 mg/dL) than OA 
(144.0 ± 42.2 mg/dL; p = 0.03) and OI (228.2 ± 96.1 mg/dL; p = 0.0003), and was lower in the 
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OA group compared to the OI group (p = 0.03). Glucose was significantly lower 1 hour after the 
meal in YA (89.4 ± 10.1 mg/dL; p = 0.01) and OA (87.3 ± 22.3 mg/dL; p = 0.005) versus OI 
(110.7 ± 26.9 mg/dL). MLI tAUC was significantly lower in YA (936.8 ± 137.7 mg/dL x 6 hr; p 
= 0.0007) and OA (1133.0 ± 207.4 mg/dL x 6 hr; p = 0.01) versus OI (1553.8 ± 394.3 mg/dL x 6 
hr), with no difference (p = 0.14) between YA and OA groups. Total-C and LDL-C were 
generally lower in younger compared to older participants at baseline and throughout the 
postprandial period, while no group or time effects were evident in HDL-C. 
Conclusion: Both physical activity status and aging appear to affect the postprandial metabolic, 
namely TG, response to a high-fat meal. These findings point to an inherently diminished 
metabolic capacity with aging, but suggest that physical activity may help minimize this 
decrement.    
 Introduction 
Cardiovascular disease (CVD) represents a serious health risk for many individuals in Western 
society. There are several lifestyle factors that are broadly accepted as modifiers of a person’s 
CVD risk, but a particular lifestyle feature that has received consistent attention over the last 
several decades is dietary intake (1). Specifically, there is evidence that consumption of a single 
high-fat meal (HFM) can increase a person’s CVD risk through a variety of mechanisms (2,3,4). 
There is a strong association between the postprandial triglyceride (TG) response and CVD risk, 
with higher non-fasting TG being related to increased CVD risk (5,6). The impact of the 
postprandial TG response (“postprandial lipemia”) is important, as individuals spend the 
majority of their day in a postprandial state (7). Other deleterious postprandial phenomena 
include evidence of a strong relationship between postprandial hyperglycemia with type 2 
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diabetes mellitus and CVD development (8,9,10), as well as a decrease in high-density 
lipoprotein cholesterol (HDL-C) following consumption of a HFM (11). 
There is a large body of evidence that suggests that exercise can be an effective means for 
reducing postprandial lipemia (12,13). Acute exercise performed 10-12 hours before, 
immediately before, or immediately after consumption of a HFM have all been found to lessen 
the postprandial TG response (14,15). However, there are indications that the capacity of 
physical activity to reduce postprandial lipemia is primarily transitory in nature (16), as active 
individuals who avoid exercise for several days prior to a HFM may exhibit a post-meal TG 
response similar to matched inactive individuals (17,18).  
Interestingly, nearly all postprandial lipemia studies, including those investigating the effects of 
exercise, involve young or middle-aged individuals. While the evidence is scarce, it appears that 
older individuals tend to exhibit a greater postprandial TG response compared to younger 
individuals (19). Nevertheless, the physiological explanations for this difference have not been 
fully elucidated, but could partially be due to decreasing physical activity with increasing age 
(20). To date, no study of which we are aware has investigated both physical activity and aging 
as potential factors in altering the postprandial HFM response. 
Therefore, the purpose of this investigation was to study the independent effects of aging and 
physical activity status on the postprandial metabolic response. We assessed postprandial 
responses to a HFM in three groups: younger active (YA), older active (OA), and older inactive 
(OI) adults. To our knowledge, no previous study has assessed the postprandial metabolic 
response in clearly defined cohorts of men and women that differ by both age and physical 
activity level. We predicted that both age and physical activity level would independently alter 
the postprandial metabolic response. Specifically, we hypothesized that: 1) Participants in the 
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YA group would exhibit a smaller postprandial TG response as compared to both OA and OI 
groups, but the OA group would show a smaller response as compared to the OI group; 2) Given 
the macronutrient composition of the test meal, there would be no differences over time or 
between groups with regard to postprandial glucose; and 3) Metabolic Load Index (MLI), 
representative of the total metabolic challenge and calculated by summing TG and glucose (21), 
in the postprandial period would be smaller in YA compared to the OA and OI groups, but OA 
would exhibit a lesser postprandial MLI response than the OI group. 
The hypotheses of the present study were based on TG and glucose (and subsequently MLI), as 
these are substrates widely recognized to change acutely following meal consumption (22). 
Total-C, LDL-C, and HDL-C were secondary metabolic markers in the current study – 
informative of overall metabolic status, but not viewed as primary outcomes in the postprandial 
period. 
 Methods 
Participants and Physical Activity Level 
Twenty-two participants participated in the present study: eight YA adults (age 18-35 years; 
4M/4W), eight OA adults (age 60+ years; 4M/4W), and six OI adults (3M/3W). Active 
participants were regularly meeting physical activity guidelines (≥150 minutes/week of 
moderate- to vigorous-intensity physical activity; MVPA) (23). Inactive participants were not 
regularly engaging in planned exercise (<30 minutes/week) and reported engaging in a generally 
inactive lifestyle (i.e. not meeting physical activity guidelines). Participants had not changed 
physical activity habits dramatically in the past five years. OA and OI adults reported to having 
been generally active or insufficiently active, respectfully, for most of their lives. Because there 
is not a validated questionnaire to assess lifetime physical activity, whether participants fit the 
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physical activity inclusion criteria was determined via extensive interviewing with an 
investigator, as has been done previously (24). Current physical activity status was objectively 
measured using accelerometry (Actical; Respironics; Bend, OR, USA). Accelerometers were 
worn on the non-dominant wrist for 5-7 continuous days, including at least 1 weekend day, and 
were initialized to record data in 30-second epochs. Participants were free of any ongoing 
chronic disease, as confirmed via medical history questionnaire. No participants were taking 
lipid-lowering medications. This study was approved by the Institutional Review Board at 
Kansas State University. 
Initial Assessment 
Participants reported to the laboratory on two occasions: an initial assessment and a meal 
assessment. The initial assessment entailed paperwork and anthropometric testing. Height was 
measured via portable stadiometer (Invictus Plastics, Leicaster, England) and weight was 
assessed using a digital scale (Pelsar LLC, Alsip, IL, USA). Height and weight were each 
measured twice, and a third measurement was performed if the values differed by more than 0.5 
cm or 0.5 kg, respectively. The values were then averaged together. Body composition was 
assessed via a dual-energy X-ray absorptiometry (DEXA) scan (GE Lunar Prodigy, Madison, 
WI, USA). 
Meal Test Protocol 
The HFM used in the present study was chocolate pie (Marie Callender’s Chocolate Satin Pie; 
Conagra Brands; Omaha, NE, USA). The primary ingredients of the pie were sugar, water, eggs, 
enriched wheat flour, soybean oil, palm oil, milk, butter, margarine, high fructose corn syrup, 
cocoa powder, and milk chocolate. The macronutrient distribution was 63% fat, 34% 
carbohydrate, and 3% protein. The amount of test meal that each participant consumed was 
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relative to their body mass (12 kcal/kg body mass; 0.84 g/kg fat, 1.02 g/kg carbohydrate, 0.09 
g/kg protein). When accounting for participant body mass, the HFM contained 927 ± 154 kcal 
across all of the participants. Table 1 displays kcal consumed in the test meal by group. The 
amount of pie consumed was generally similar to a typical serving at a restaurant or social 
gathering (1-2 servings). 
Participants were instructed to avoid planned exercise for two full days before their main 
assessment. Participants were given a 270-kcal snack (Little Debbie Swiss Cake Roll; McKee 
Foods; Collegedale, TN, USA) that they were instructed to consume in the evening, ten hours 
prior to their appointment.  
On the morning of the meal assessment, participants arrived to the laboratory after a 10-hour 
overnight fast. An indwelling safelet catheter was inserted into a forearm vein via 24-gauge 
needle (Exelint International, Redondo Beach, CA, USA). The catheter was kept clear with a 
consistent infusion of 0.9% NaCl solution (~1 drip/second) and maintained stationary via 
placement of tegaderm film (3M Healthcare, Neuss, Germany). When the catheter was set in 
place, a fasting blood draw was conducted. For each blood draw, a 3 mL syringe (BD, Franklin 
Lakes, NJ, USA) was used to remove saline from the line, after which the actual blood sample 
was drawn into a 5 mL syringe (BD, Franklin Lakes, NJ, USA). The 5 mL syringe was emptied 
into a 6 mL Vacutainer test tube (BD, Franklin Lakes, NJ, USA) coated with EDTA 
(anticoagulant) and inverted three times to ensure adequate mixing with the EDTA. Whole blood 
from the blood draws was utilized to measure TG, glucose, total cholesterol (Total-C), and high-
density lipoprotein cholesterol (HDL-C) using a Cholestech LDX analyzer (Alere Cholestech, 
San Diego, CA, USA). Low-density lipoprotein cholesterol (LDL-C) was calculated by the LDX 
analyzer using the Friedewald equation (25). For each blood sample, a few drops of whole blood 
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were drawn into a capillary tube and plunged into a Cholestech LDX Lipid+Glu cassette (Alere 
Cholestech, San Diego, CA, USA). The cassette was then placed in the Cholestech LDX 
analyzer for measurement. After the baseline blood draw, participants consumed the test meal 
within 20 minutes. Water was available ad libitum with the meal and during the post-meal 
period. Participants stayed in the laboratory for six hours after consumption of the test meal (the 
six-hour time period began after the last bite of the test meal). Blood draws were conducted 
serially each hour for six hours post-HFM. 
Statistical Analyses 
An a priori sample size calculation based on the findings of previous studies (26,27) revealed 
that 3-5 participants would need to be recruited to each group to detect statistically significant 
differences in the postprandial TG response (power = 0.80; α = 0.05). We aimed to recruit 8 
participants to each group (24 participants total) in order to increase power to detect differences 
in other metabolic markers. However, due to the considerable challenge of recruiting inactive 
individuals over age 60 who were not taking lipid-lowering medications, only 6 participants 
recruited to the OA group met our a priori inclusion criteria.  
MLI is calculated by adding TG and glucose values. As postprandial TG and glucose responses 
have been shown to be interrelated (28,29), MLI is intended to represent the cumulative 
metabolic challenge faced by the body, either fasting or following a meal (21).  
Total area under the curve (tAUC), incremental area under the curve (iAUC), peak value, and 
time to peak value were determined for each of the metabolic markers. tAUC and iAUC were 
calculated using the trapezoid method. All data were assessed for normality via Shapiro-Wilk 
formal normality test and analysis of frequency distribution. If data were not normally 
distributed, a square root transformation was performed. Differences between groups with regard 
117 
 
to participant characteristics and postprandial values were tested via one-way Analysis of 
Variance (ANOVA) with Holm-Sidak adjustment for multiple comparisons. However, since 
iAUC analyses can potentially produce negative values, a square root transformation was not 
performed. Instead, a non-parametric Friedman test was utilized to test for group differences if 
iAUC data were not normally distributed.  
Time-course changes in metabolic markers in the postprandial period were determined via two-
way (group x time) repeated measures ANOVA with a Tukey’s adjustment for multiple 
comparisons. A type 1 error rate of 0.05 was used in all analyses for the determination of 
statistically significant differences. Statistical analyses were conducted using GraphPad Prism 
statistical software (Version 6.05; GraphPad Software, Inc; La Jolla, CA). 
 Results 
Participant Characteristics 
Participant characteristics are displayed in Table 1. The YA group was younger than the OA (p < 
0.0001) and the OI (p < 0.0001) groups. The OA and OI groups did not differ in age (p = 0.60). 
With regard to anthropometric variables, there were no differences between groups (p > 0.05) 
with respect to height, body mass, body mass index (BMI), or percentage body fat. However, the 
OI group had significantly more trunk fat compared to the YA group (p = 0.02), although there 
were no differences between YA and OA (p = 0.09) or OA and OI (p = 0.33). 
Physical Activity Level 
There was no difference in steps/day in the YA group versus the OA group (p = 0.56) or the OA 
group compared to the OI group (p = 0.06). However, the YA group did obtain significantly 
more steps than the OI group (p = 0.03). With regard to minutes per day spent in MVPA, the YA 
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and OA groups both engaged in more MVPA compared to the OI group (p = 0.01; p = 0.003, 
respectively), while YA and OA did not differ (p = 0.44). 
Fasting Values 
There was no difference in fasting TG in the YA group compared to the OA group (p = 0.55) or 
the OA group compared to the OI group (p = 0.07). Fasting TG was significantly lower in the 
YA group versus the OI group (p = 0.03). No participants presented with fasting TG >150 mg/dL 
and only one participant (belonging to the OI group) had fasting TG >100 mg/dL (136 mg/dL). 
Thus, all participants presented with optimal fasting TG. There were no group differences (p > 
0.05) with regard to fasting glucose. However, fasting MLI was higher in the OI adults compared 
to both the YA (p = 0.01) and OA adults (p = 0.03), with no difference between the YA and OA 
(p = 0.62). Fasting Total-C was not different between groups (p > 0.05). Only one participant (an 
OI adult) presented with fasting total cholesterol >200 mg/dL (209 mg/dL). Fasting Total-C was 
in the optimal range for all other participants. There were group differences with regard to 
fasting LDL-C, as OA had higher LDL-C levels compared to YA (p = 0.04). However, the OI 
group was not different from the YA group (p = 0.06) or the OA group (p = 0.80). No 
participants presented with fasting LDL-C greater than 129 mg/dL, the upper limit for optimal 
fasting LDL-C. There were no group differences with regard to fasting HDL-C (p > 0.05). Three 
participants (1 YA, 2 OI) had below-optimal HDL-C (40-60 mg/dL). 
Postprandial Metabolic Responses 
Postprandial metabolic values and time-course responses are presented in Table 3 and Figures 1 
and 2, respectively. In a two-way repeated measures ANOVA, a significant group x time 
interaction was detected in the postprandial TG response (p < 0.0001). TG peaked at a 
significantly lower level in the YA group compared to the OA (p = 0.03) and OI (p = 0.0003) 
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groups, while the OA group peaked at a significantly lower level than the OI group (p = 0.03). 
TG tAUC (representative of the total magnitude and duration of the postprandial response for the 
6-hour period) was lower in YA adults versus OA adults (p = 0.02) and OI adults (p = 0.0002), 
whereas TG tAUC was lower in OA adults compared to OI adults (p = 0.02). With regard to TG 
iAUC (representative of the magnitude and duration of the postprandial response above 
fasting/baseline), YA had a lower response than OA (p = 0.006) and OI (p = 0.0002), with no 
difference (p = 0.06) in OA and OI groups. 
For the postprandial glucose response, there was no significant group x time interaction 
following the HFM (p = 0.24), although there was a significant time effect (p = 0.002). There 
was a significant group effect (p = 0.04) for peak glucose values. However, no group pairwise 
comparisons were statistically significant (p > 0.05). With the exception of a few time-point 
specific differences (Figure 1), there were no other significant differences between groups in the 
postprandial glucose response.  
The repeated measures two-way ANOVA revealed a significant group x time interaction in the 
MLI response to the HFM (p = 0.004). The OI group exhibited a greater MLI peak compared to 
the YA (p = 0.0007) and OA (p = 0.02) groups, while there was no difference between YA and 
OA (p = 0.09). With regard to tAUC, there was no difference between the YA and OA groups 
(Mean diff: -196.2 mg/dL x 6 hr; 95% CI: (-516.9, 124.5); p = 0.14), but the OI group exhibited 
a greater MLI response compared to YA (Mean diff: 617.0 mg/dL x 6 hr; 95% CI: (270.6, 
963.4); p = 0.0007) and OA (Mean diff: 420.8 mg/dL x 6 hr; 95% CI: (74.4, 767.2); p = 0.01). 
The YA group also displayed a significantly lower (Mean diff: -375.9 mg/dL x 6 hr; 95% CI: (-
614.7, -137.2); p = 0.002) MLI iAUC response compared to the OI group, with no difference 
120 
 
between YA and OA (Mean diff: -160.9 mg/dL x 6 hr; 95% CI: (-381.9, 60.2); p = 0.08) or OA 
and OI (Mean diff: -215.0 mg/dL x 6 hr; 95% CI: (-453.8, 23.7); p = 0.07).  
Postprandial Total-C levels in each group are presented in Figure 2. No significant group x time 
interaction was observed in Total-C (p = 0.49), although there was a significant group effect (p = 
0.004). Peak Total-C levels were lower in the YA group compared to the OA (Mean diff: -36.8 
mg/dL; 95% CI: (-64.2, -9.3); p = 0.009) and OI (Mean diff: -32.7 mg/dL; 95% CI: (-62.4, -3.1); 
p = 0.02) groups, with no difference between OA and OI (Mean diff: 4.04 mg/dL; 95% CI: (-
25.6, 33.7); p = 0.73). Total-C tAUC was significantly lower in YA compared to OA (Mean diff: 
-219.8 mg/dL x 6 hr; 95% CI: (-370.9, -68.6); p = 0.005) and OI (Mean diff: -189.9 mg/dL x 6 
hr; 95% CI: (-353.2, -26.7); p = 0.02), but there was no difference between OA and OI (Mean 
diff: 29.8 mg/dL x 6 hr; 95% CI: (-133.4, 193.1); p = 0.65).  
With regard to LDL-C, in a two-way repeated measures ANOVA, although there was no 
significant group x time interaction (p = 0.46), significant time (p < 0.0001) and group (p = 0.03) 
effects were detected. YA adults exhibited a significantly lower LDL-C peak compared to OA (p 
= 0.02) and OI (p = 0.04) adults, with no difference between OA and OI adults (p = 0.68). The 
LDL-C tAUC response was lower (Mean diff: -151.5 mg/dL x 6 hr; 95% CI: (-285.3, -17.8); p = 
0.03) in the YA group versus the OA group, but there was no difference in YA versus OI (Mean 
diff: -95.9 mg/dL x 6 hr; 95% CI: (-238.9, 47.1); p = 0.20) or OA versus OI (Mean diff: 55.6 
mg/dL x 6 hr; 95% CI: (-78.1, 189.4); p = 0.30). 
There was no significant group x time interaction (p = 0.47) with regard to HDL-C. There were 
also no statistical group differences (p > 0.05) in peak, time to peak, tAUC, or iAUC. 
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 Discussion 
Main Findings 
The main finding of the present study was the distinct difference in the postprandial TG response 
between the three groups. Supporting our first hypothesis, the YA group exhibited an attenuated 
postprandial lipemic response relative to OA and OI groups, and OA displayed a tempered 
response compared to OI. These findings suggest that both age and physical activity status 
independently impact the postprandial TG response. With regard to our second hypothesis, we 
predicted no group- or time-based differences in the postprandial glycemic response. 
Interestingly, we found that glucose was significantly higher in the OI group compared to the YA 
and OA groups one hour after the HFM, although there was not an overall group x time 
interaction. Finally, in partial agreement with our third hypothesis, the YA and OA groups 
displayed smaller postprandial MLI responses compared to the OI group, with no differences 
between YA and OA groups. 
Postprandial TG Responses 
While there is a well-established connection between postprandial lipemia and CVD risk (30), 
most studies investigating postprandial lipemia have utilized young and middle-aged individuals, 
as opposed to older adults (31,32). This omission is problematic, considering that: 1) older 
individuals are at a higher risk for CVD (33), and 2) older adults, as a segment of the population, 
are becoming more numerous in Western society (34). The current study found an age-related 
increase in postprandial lipemia: YA adults showed a comprehensively lower postprandial TG 
response compared to OA and OI adults. The finding of an increase in the postprandial lipemic 
response with age is in agreement with previous studies (26, 27, 35-38). However, the reason(s) 
for the greater postprandial TG response in older individuals remains unclear, with several 
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potential mechanisms in consideration (19). First, there is evidence that lipoprotein lipase (LPL) 
activity decreases with age (39). As LPL is the rate-limiting step for the clearance of TG in 
circulation (19), the increase in postprandial lipemia with age could be partly due to a decrease in 
LPL activity. Next, age-related changes in liver physiology result in impairment of uptake and 
metabolism of chylomicron remnants, including the TG portion (40). Related to this, liver fat 
content is typically higher in older individuals (41), and there is evidence that increased liver fat 
content is accompanied by increased circulating lipid concentrations, including TG (42). 
Therefore, there are several potential physiological explanations for the greater postprandial TG 
response displayed by older adults. 
To our knowledge, only one previous study has assessed postprandial lipemia in older adults, 
while also considering chronic physical activity level (27). Miyashita and colleagues (27) tested 
the postprandial TG response in 26 older adults (mean age: ~70 years), divided into active and 
inactive groups based on whether they obtained less or more than 150 minutes per week of 
MVPA. The authors found a significantly lower postprandial TG response in the active older 
adults, despite requiring that all participants avoid physical activity for 48 hours prior to their 
assessment. There are several noteworthy differences in study design between the present 
investigation and that of Miyashita et al. (27), including that the present study matched groups by 
sex, obtained metabolic values every hour post-meal (instead of every other hour), and utilized a 
fattier test meal (63% vs 35% kcal from fat). Despite these differences, both investigations found 
a significantly lower postprandial lipemic response in OA than OI groups. These data disagree 
with the previously accepted notion that the lipid-lowering effects of physical activity were 
limited to the acute time-frame, as OA adults appear to experience a lesser post-meal TG 
response than their inactive counterparts, even when required to abstain from exercise for two 
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days prior to the meal. Therefore, there are potentially chronic physical activity effects on the 
postprandial TG response in older adults that may not be present in younger individuals. 
Finally, the most notable difference between the present study and that of Miyashita and 
colleagues (27) is that our study included a YA group. In doing so, the present study was 
designed to assess whether both aging and physical activity impacted the postprandial TG 
response. Results from the current investigation indicated that there was a lower lipemic 
response in OA compared to OI, while YA exhibited the lowest lipemic response of the three 
groups. As there were no differences between the YA and OA groups with regard to physical 
activity level, it appears that both physical activity status and aging may have independent 
effects on the postprandial lipemic response. 
Other Metabolic Markers 
For glucose, there were no group differences with regard to the primary postprandial indices. 
This is not surprising, given the quicker postprandial response of glucose relative to TG, so that 
group differences would be difficult to detect over a six-hour period. Notably, we did find that 
glucose was significantly higher in the OI group compared to the YA and OA groups one hour 
after the meal. This finding was unexpected, since the HFM only included 34% of kcals as 
carbohydrate. While the present study was not designed or intended to robustly assess glucose 
tolerance, our findings point to potentially greater capacity for glucose clearance in OA adults 
compared to OI adults. 
In accordance with this, we also utilized the MLI response to the HFM in assessing postprandial 
metabolism in the three groups. Noteworthy group differences were exhibited with regard to both 
TG and glucose, but these differences generally occurred at different phases of the postprandial 
period. Specifically, there were group differences in glucose (but not TG) early in the 
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postprandial period, while group differences were evident in TG (but not glucose) later in the 
postprandial period. However, consideration of the postprandial MLI response reveals significant 
group differences throughout the postprandial period. Thus, the metabolic differences between 
active and inactive adults in the present study were not merely an issue of lipid clearance or 
glucose uptake, but an overall difference in metabolic capacity to clear the mixed meal, as 
represented by the group differences in MLI throughout the postprandial period. (However, it 
should be noted that the mixed meal in the present study was 63% fat, 34% carbohydrate. Thus, 
the MLI response primarily represents the postprandial lipemic response.) As both elevated 
postprandial glycemia and lipemia have been independently linked to CVD risk (21,22), this 
finding of an overall diminished metabolic capacity in OI adults is noteworthy. 
Previous research suggests that Total-C is elevated in older individuals compared to younger 
individuals (43), and that it is not very responsive in the acute postprandial period (44). These 
notions were supported by the present findings, as Total-C was lower at baseline and throughout 
the postprandial period in the younger adults compared to the older adults, and there was no 
main effect of time for Total-C. Additionally, despite previous evidence suggesting lower Total-
C in regularly active individuals (45), the lack of difference between the OA and OI adults is not 
surprising, since we excluded individuals who were taking lipid-lowering medication.  
In the present study, although it was generally lower in the younger adults, LDL-C did not 
dramatically change in the postprandial period in any of the groups. On the other hand, it has 
previously been demonstrated that HDL-C has a tendency to decrease following consumption of 
a HFM, another potentially deleterious feature of the postprandial metabolic response (11). 
Accordingly, we hypothesized that we would see a decrease in HDL-C following the HFM, with 
the OI adults displaying the greatest decrease and that YA adults showing the most negligible 
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decrease. Contrary to expectation, we found no changes in the postprandial period, or differences 
among groups, with regard to HDL-C. The explanation for this null finding remains unclear. 
Strengths and Experimental Considerations 
There are several strengths of the present investigation that deserve to be highlighted. First, a 
strong point of the present study is its realistic test meal. Prior postprandial metabolic studies 
have tended to utilize test meals that are not very “true-to-life” (e.g. 1500 kcal) (46). In the 
present investigation, the average kcal value for the test meal was ~930 kcal. Thus, while the 
meal was not small, it was nevertheless considerably smaller than many previous studies (46), 
and yet, in our view, still representative of an unhealthy Western meal. Finally, an asset of this 
study was the blood sample frequency and the duration of postprandial period. It is ideal to 
collect frequent blood samples during the postprandial period to optimally characterize the 
response curve. With regard to duration of assessment, measuring the postprandial TG response 
for four hours is typically sufficient (47). However, as older adults tend to have a delayed TG 
response relative to younger adults, it is imperative that postprandial metabolic tests in older 
adults extend beyond four hours (19). In utilizing a six-hour postprandial period, with hourly 
blood samples, we view the present study to be well-suited to characterize the postprandial 
metabolic response. 
However, the present study is not without limitations, and considerations need to be made in 
interpreting the findings. First, the present study did not include a younger inactive group. The 
primary research purpose was to determine whether there were independent effects of aging and 
chronic physical activity on the postprandial response. We did not view including a younger 
inactive group as pertinent to accomplishing this purpose. Specifically, we were most interested 
in comparing YA adults to OA adults, and OA adults to OI adults. Further, the comparison 
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between younger active and inactive individuals has been tested numerous times in the past (16). 
Consequently, we directed our resources toward obtaining sufficient data to adequately answer 
our research question with the essential YA, OA, and OI groups. However, relevant to our 
research question, had we included a younger inactive group, we could have compared the 
effects of physical activity in younger participants to the activity effects in older participants. 
Thus, we acknowledge not including a younger inactive group as a limitation. Another 
consideration is the limited degree to which we can connect the postprandial responses in the 
present study to CVD risk. While there is a fasting TG recommendation of <150 mg/dL (48), and 
on average the OI group exceeded this cut point for most of the postprandial period, there is no 
established post-meal TG cut point for increased CVD risk. However, an expert panel statement 
has suggested non-fasting TG ≥180 mg/dL is “undesirable” (49). More research is needed to 
better determine TG reference ranges that represent increased risk in the acute postprandial 
period. Similarly, MLI is a novel, recently proposed marker of metabolic status. As such, the 
strength of MLI as an independent CVD risk factor is yet to be determined, and no cut points 
exist for fasting and postprandial MLI. Therefore, at this point, the higher MLI response in OI 
participants cannot be directly linked to increased CVD risk. Next, it was crucial that individuals 
on lipid-lowering medications be excluded from the present study. However, not only does this 
requirement make recruiting more difficult, but it potentially limits external applicability for the 
OI group. There were simply not very many OI individuals who were not on lipid-lowering 
medications in our target population. However, it could be argued that OI individuals on lipid-
lowering medications could, theoretically, display a similar response as the OI adults in the 
present study who were not on lipid-lowering medications. This is an interesting issue, and 
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should be investigated further. In addition, given the important roles of insulin in regulating 
substrate utilization, it would have been valuable to assess fasting and postprandial insulin. 
Conclusion and Future Directions 
We found that both aging and physical activity level likely impact the postprandial TG response, 
as YA exhibited a lesser response than OA and OI groups, but OA adults showed a reduced 
response compared to OI. OI adults also displayed higher glucose in the 1-2 hours post-meal, 
pointing to an overall diminished capacity for metabolic clearance, as supported by the MLI 
findings. Overall, these findings point to the possibility of an age-related decline in metabolic 
clearance capacity, but this deterioration can be partially alleviated with chronic physical activity 
– an important public health message. Future research should continue to study the relationship 
between physical activity, postprandial metabolism, and CVD risk in aging individuals, as older 
adults represent a growing segment of the population that is at increased risk for CVD 
development.
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 Tables 
  
Younger Active 
n=8 
Older Active 
n=8 
Older Inactive 
n=6   
P-value 
 
Age (years) 25.1 ± 4.8a 66.5 ± 5.2b 68.2 ± 7.4b  <0.0001 
Height (cm) 174.2 ± 10.8 175.0 ± 8.8 168.3 ± 8.5  0.40 
Body mass (kg) 71.9 ± 10.4 81.6 ± 15.4 78.6 ± 11.3  0.32 
Body mass index (kg/m2) 23.6 ± 2.0 26.6 ± 4.1 27.9 ± 4.7  0.11 
Body fat (%) 21.5 ± 8.9 30.0 ± 11.7 33.4 ± 8.9  0.09 
Trunk fat (%) 22.5 ± 9.2a 32.6 ± 11.5ab 37.7 ± 5.9b  0.02 
Steps (x103)/day 16.6 ± 6.5a 14.9 ± 5.5ab 8.8 ± 2.8b  0.03 
MVPA (minutes/day) 159.4 ± 48.6a 182.4 ± 77.1a 62.3 ± 14.1b  0.003 
Test meal energy (kcal) 863 ± 125 980 ± 185 943 ± 136  0.32 
 
Table 5-1. Participant characteristics. 
Data are Mean ± SD. The P-value column denotes main effects between groups assessed via 
one-way ANOVA. Within main effects (by row), column values with shared superscript letters 
are not significantly differrent, determined by post hoc pairwise comparisons. Rows with no 
superscript letters present contain no significant differences. See Results section for post hoc 
pairwise comparison p-values. 
n, number of participants; MVPA, moderate- to vigorous-intensity physical activity 
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Fasting Values 
(mg/dL) 
Optimal Values 
(mg/dL) 
Younger Active 
n=8 
Older Active 
n=8 
Older Inactive 
n=6 
P-value 
 
TG  < 150 47.4 ± 4.6a 52.3 ± 9.0ab 75.8 ± 35.3b 0.03 
Glucose  < 100 89.6 ± 11.2 90.6 ± 8.3 101.3 ± 9.7 0.08 
MLI  N/A 137.0 ± 11.5a 142.9 ± 15.0a 177.2 ± 39.5b 0.01 
Total-C  < 200 137.5 ± 24.5 165.4 ± 18.1 165.8 ± 32.1 0.06 
LDL-C  100-129 76.3 ± 18.9a 103.9 ± 17.1b 101.3 ± 19.9ab 0.03 
HDL-C  40-60 52.0 ± 10.9 50.8 ± 6.0 48.3 ± 17.4 0.84 
 
Table 5-2. Metabolic values measured in fasting participants. 
Data are Mean ± SD. The P-value column denotes main effects between groups assessed via 
one-way ANOVA. Within main effects (by row), column values with shared superscript letters 
are not significantly different, determined by post hoc pairwise comparisons. Rows with no 
superscript letters present contain no significant differences. Optimal values are based on 
references 48 and 50. 
n, number of participants; TG, triglycerides; MLI, metabolic load index; Total-C, total 
cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein 
cholesterol 
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Younger Active 
n=8 
Older Active 
n=8 
Older Inactive 
n=6 
P-value 
 
Triglycerides     
Peak (mg/dL)  82.0 (75.5-97.5)a 133.0 (120.3-160.0)b 182.0 (155.3-341.5)c 0.0004 
Time to peak (hours) 3.5 (2.0-4.0) 4.0 (3.0-4.8) 4.5 (3.0-5.0) 0.18 
tAUC (mg/dL 6 hr) 372.8 (334.0-436.1)a 570.0 (486.5-712.3)b 794.8 (677.6-1367.0)c 0.0003 
iAUC (mg/dL 6 hr) 78.3 (59.3-154.6)a 288.0 (216.5-358.3)b 453.0 (307.3-687.8)b 0.0002 
Glucose     
Peak (mg/dL) 99.9 ± 7.8 99.0 ± 16.4 118.2 ± 17.2 0.04 
Time to peak (hours) 1.5 (0.0-3.5) 1.0 (0.0-3.8) 1.0 (0.8-1.3) 0.96 
tAUC (mg/dL 6 hr) 528.9 ± 43.2 507.3 ± 82.2 592.5 ± 59.9 0.07 
iAUC (mg/dL 6 hr) -8.9 ± 58.5 -36.4 ± 49.5 -15.5 ± 44.9 0.56 
Metabolic Load Index     
Peak (mg/dL) 174.0 (165.3-193.5)a 222.0 (207.0-245.8)a 275.0 (256.3-445.3)b 0.0009 
Time to peak (hours) 3.4 ± 1.1 3.6 ± 0.9 4.2 ± 1.0 0.35 
tAUC (mg/dL 6 hr) 936.8 ± 137.7a 1133.0 ± 207.4a 1553.8 ± 394.3b 0.0009 
iAUC (mg/dL 6 hr) 114.8 ± 131.2a 275.6 ± 135.1ab 490.7 ± 255.7b 0.003 
Total Cholesterol     
Peak (mg/dL) 144.1 ± 24.2a 180.9 ± 13.8b 176.8 ± 26.2b 0.006 
Time to peak (hours) 2.1 ± 2.0 3.1 ± 1.4 2.8 ± 2.3 0.56 
tAUC (mg/dL 6 hr) 803.8 ± 123.8a 1023.5 ± 84.0b 993.7 ± 149.9b 0.003 
iAUC (mg/dL 6 hr) -21.3 ± 57.6 31.1 ± 53.9 -1.4 ± 54.1 0.19 
LDL-Cholesterol     
Peak (mg/dL) 77.5 (65.5-90.5)a 104.5 (95.8-123.5)b 106.0 (87.0-122.0)b 0.01 
Time to peak (hours) 1.0 (0.0-6.0) 1.0 (0.0-3.5) 0.0 (0.0-1.5) 0.52 
tAUC (mg/dL 6 hr) 427.9 ± 88.4a 579.4 ± 80.2b 523.8 ± 121.9ab 0.03 
iAUC (mg/dL 6 hr) -30.1 ± 39.5 -43.8 ± 41.1 -84.2 ± 64.7 0.16 
HDL-Cholesterol     
Peak (mg/dL) 57.5 ± 11.9 56.4 ± 9.0 51.0 ± 17.7 0.62 
Time to peak (hours) 3.4 ± 2.1 2.6 ± 2.3 1.8 ± 2.3 0.45 
tAUC (mg/dL 6 hr) 305.8 ± 67.4 317.2 ± 47.1 276.9 ± 106.1 0.60 
iAUC (mg/dL 6 hr) -6.2 ± 17.4 12.7 ± 27.0 -13.1 ± 19.9 0.10 
 
Table 5-3. Postprandial metabolic outcomes. 
Normally distributed data are Mean ± SD, and non-normally distributed data are Median 
(Interquartile Range). Non-normally distributed data were transformed before analysis. A one-
way ANOVA was conducted to test for differences between groups. However, due to negative 
numbers, a non-parametric Friedman test was conducted for TG iAUC. The P-value column 
denotes main effects between groups assessed via one-way ANOVA. Within main effects (by 
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row), column values with shared superscript letters are not significantly different, determined by 
post hoc pairwise comparisons. Rows with no superscript letters present contain no significant 
differences. See Results section for post hoc pairwise comparison p-values. 
tAUC, total area under the curve; iAUC, incremental area under the curve; LDL, low-density 
lipoprotein, HDL, high-density lipoprotein; ANOVA, analysis of variance 
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 Figures 
 
Figure 5-1. Postprandial responses for triglycerides, glucose, and metabolic load index. 
Triglycerides (top panel), glucose (middle panel), and metabolic load index (bottom panel) were 
assessed at baseline/fasting (time 0) and serially for six hours after the high-fat meal. Significant 
differences (p < 0.05) at specific time-points reflect the results of a two-way (group x time) 
repeated measures ANOVA. Error bars reflect standard error. 
* YA vs OA; ^ YA vs OI; # OA vs OI 
YA, younger active adults; OA, older active adults; OI, older inactive adults 
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Figure 5-2. Postprandial cholesterol responses. 
Total cholesterol (top panel), LDL-C (middle panel), and HDL-C (bottom panel) were assessed 
at baseline/fasting (time 0) and serially for six hours after the high-fat meal. Significant 
differences (p < 0.05) at specific time-points reflect the results of a two-way (group x time) 
repeated measures ANOVA. Error bars reflect standard error. 
* YA vs OA; ^ YA vs OI; # OA vs OI 
YA, younger active adults; OA, older active adults; OI, older inactive adults; LDL-C, low-
density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol 
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Chapter 6 - Conclusion 
Large postprandial metabolic fluxes and inflammation have been shown to be linked to CVD risk 
through a variety of mechanisms. Given this link, the present dissertation sought to better 
understand the relationship between single-meal intake and postprandial metabolic and 
inflammatory responses. Collectively, this series of papers 1) proposed a novel index of 
metabolic challenge (MLI) that considers both glucose and TG; 2) characterized the magnitude 
and timing of the postprandial response for IL-6, the only marker systematically shown to 
increase in circulation following a HFM; 3) revealed the substantially different postprandial 
metabolic responses induced by a HFM, representative of meals used in previous postprandial 
studies, compared to more “true-to-life” meals; and 4) showed that aging and chronic physical 
activity level independently influence the postprandial metabolic response to a HFM.  
In the Chapter 2, we reviewed the evidence connecting both postprandial glycemia and lipemia 
to chronic disease risk. Since large glucose and TG fluctuations appear to alter CVD risk through 
similar mechanisms, we suggested the utility of a single metabolic index intended to represent 
the total metabolic challenge experienced by the body. The novel MLI, simply the sum of 
glucose and TG in circulation, was formally proposed (then used as a metabolic outcome in 
Chapters 4 and 5). We are optimistic that MLI will be increasingly used in research and clinical 
environments.  
In the Chapter 3, the focus shifted from postprandial metabolism to postprandial inflammation. 
We conducted the first systematic review attempting to characterize the magnitude and timing of 
the postprandial inflammatory response for five commonly assessed markers of inflammation. 
Interleukin-6 was the only assessed inflammatory marker found to consistently increase in 
response to a HFM, starting at a baseline of ~1.4 pg/mL and peaking at ~2.9 pg/mL 
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approximately six hours after the meal. On the other hand, CRP, TNF-α, IL-1β, and IL-8 
infrequently changed in response to a HFM. Therefore, we propose that future postprandial 
inflammatory research should focus on IL-6, as well as other novel inflammatory markers. 
Chapter 4 was a randomized cross-over trial comparing the postprandial metabolic and 
inflammatory responses to three meal conditions: HFM (17 kcal/kg; 63% fat), MFM (8.5 
kcal/kg; 30% fat), and a BPM, in which participants consumed the MFM twice, separated by 
three hours. We found a significantly greater TG tAUC response following the HFM compared 
to both the MFM and BPM, with no difference between the MFM and BPM. Additionally, the 
TG peak was significantly greater following HFM compared to MFM, although there was no 
difference between HFM and BPM. These findings suggest that the large TG responses seen in 
previous postprandial studies may not be reflective of the metabolic challenge experienced by 
many individuals in daily life. 
Finally, Chapter 5 investigated the postprandial metabolic responses to a single HFM (12 
kcal/kg; 63% fat) in three groups of healthy adults: YA, OA, and OI adults. Assessed via several 
indices, the largest postprandial TG response was exhibited by the OI adults, followed by the OA 
adults. Despite similar levels of physical activity, YA displayed a significantly lower 
postprandial TG response relative to OA adults. Further, glucose was significantly greater in OI 
adults compared to OA and YA adults one hour post-meal. Overall, these findings point to a 
diminished metabolic capacity that accompanies aging, in agreement with the MLI results. 
However, this age-related metabolic decline can be partially ameliorated by higher levels of 
chronic physical activity. 
In conclusion, this series of papers enhances our understanding of the relationship between diet 
and CVD risk by focusing on the acute metabolic and inflammatory responses to single-meal 
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intake. Aging, chronic physical activity level, meal size, meal macronutrient distribution, and 
meal frequency are all factors that appear to modify the postprandial response. Considering the 
connection between the postprandial response and CVD risk, and that many individuals spend 
most of their day in the postprandial state, our findings have clear real-life relevance, as well as 
the potential to enhance clinical understanding. Additionally, our results point to intriguing 
future research endeavors, such as testing the strength of MLI (fasting or postprandial) to predict 
disease risk compared to TG and glucose alone, further investigating the role of the postprandial 
increase in IL-6 in CVD development, studying other meal consumption factors that can 
minimize postprandial fluxes, and further investigating the physiological mechanisms behind 
aging and chronic physical activity with regard to their modification of the postprandial 
response.   
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ARTICLE (REF) MEAL BLOOD S/P MO FAT ENERGY N M/F AGE BMI PPP ↑↓↔ TTP FASTING PEAK QA 
     %E kcal   y kg/m2 hrs  hrs CRP, mg/mL CRP, mg/mL  
Bell et al. 2010 [1] Heavy whipping cream, water venipuncture P N 68 1200 10 0M/10W 29 ± 11 22 ± 3 6 ↔ - 2.03 ± 1.43 - 6.5 
Bidwell et al. 2014 (15) Eggs, muffin, butter, sugary drink cannula P N 40 600 22 11M/11F 
M: 20.8 ± 0.7 
F: 21.5 ± 0.9 
M: 23.9 ± 0.9 
F: 21.1 ± 0.5 
6 ↑ NS NS NS 6 
Blum et al. 2006 - Med meal (77) Vegetables, olive oil, orange juice, cheese, bread, yogurt, fish NS P N 43 982 10 10M/0F 26.6 ± 1.1 24.86 ± 0.80 7 ↓ 2 1.5 (0.35 - 3.15) NS 2.5 
Blum et al. 2006 - Wes meal (77) White bread, egg, sour cream, cheese NS P N 46 972 10 10M/0F 26.6 ± 1.1 24.86 ± 0.80 7 ↔ - 1.5 (0.35 - 3.15) - 2.5 
Caixas et al. 2008 – lean (18) Liquid test meal cannula P Y 30 750 7 6M/1F 23.0 (21.0 - 26.0) 20.3 (18.9 - 25.1) 6 ↔ - 0.65 (0.36 - 4.85) - 4 
Caixas et al. 2008 – obese (18) Liquid test meal cannula P Y 30 750 7 6M/1F 26.0 (23.0 - 27.0) 43.9 (32.8 - 48.0) 6 ↔ - 3.37 (2.79 - 9.48) - 4 
Campbell et al. 2006 (19) Apple muffins, milk shake venipuncture S N 41 976 15 15M/0F 28 ± 9 NS 6 ↔ - 0.1 ± 0.04 - 6.5 
Coutinho et al. 2008 [2] Milk cream, egg yolk NS S Y 74 683 28 13M/15F 39.96 ± 6.29 23.38 ± 2.41 5 ↔ - 1.34 ± 1.40 - 2.5 
Dandona et al. 2015 [3] Egg, sausage, muffin, hash browns NS P N 42 910 10 6M/4F 33 ± 4 22.8 ± 0.7 5 ↔ - 1.33 ± 0.3 - 2.5 
Denniss et al. 2008 [4] Egg, sausage, muffin, hash browns, milk venipuncture S N 49 1107 18 18M/0F 23 ± 2 20 - 30 3 ↔ - 0.41 ± 0.35 - 4 
Esser et al. 2013 (23) Milk shake (cream, sugar, water) cannula P Y 85 954 20 20M/0F 22 ± 2 22.7 ± 2.4 6 ↔ - 0.46 ± 0.62 - 5 
Ghanim et al. 2009 (78) Egg, sausage, muffin, hash browns NS P N 42 910 10 5M/5F 32.4 ± 1.3 23.1 ± 0.6 3 ↔ - 1.43 ± 0.2 - 3 
Johnson et al. 2016 (28) Ice cream, whipping cream cannula P N 45 1360 - 2160 12 12M/0F 23.0 ± 3.2 24.5 ± 2.7 4 ↔ - 0.25 ± 0.32 - 4 
Kackov et al. 2013 [5] French bread, salami, cheese, margarine venipuncture S N 55 823 102 102M/0F 58 (52 - 68) 28.3 ± 3.8 3 ↔ - 1.72 (0.88 - 3.04) - 4 
Neri et al. 2010 [6] Homogenized milkshake NS S N NS 1480 40 20M/20W 41 ± 2 23 ± 1 2 ↑ 2 1.48 ± 0.60 2.98 ± 0.70 4 
Payette et al. 2009 - Men (36) Cheese, eggs, toast, butter, cream, milk, peanut butter cannula P Y 64 1600 - 2200 39 39M/0F 44.0 ± 9.1 28.9 ± 4.3 8 ↔ - 2.02 ± 2.30 - 5 
Payette et al. 2009 - Women (36) Cheese, eggs, toast, butter, cream, milk, peanut butter cannula P Y 64 1600 - 2200 41 0M/41F 43.7 ± 9.4 26.5 ± 5.7 8 ↔ - 1.96 ± 2.03 - 5 
Phillips et al. 2013 – Lean (38) Bacon, egg, muffin, hash browns, milk cannula P N 52 989 10 10M/0W 43.4 ± 11.3 22.8 ± 1.5 6 ↑ 6 0.2 ± 0.1 NS 6 
Phillips et al. 2013 – Obese (38) Bacon, egg, muffin, hash browns, milk cannula P N 52 989 10 10M/0W 40.9 ± 9.8 38.2 ± 6.7 6 ↑ 6 1.3 ± 0.4 NS 6 
Poppitt et al. 2008 (39) Blueberry muffin cannula S Y 71 748 18 18M/0F 23 ± 4 22.9 ± 2.0 6 ↔ - 0.51 ± 0.1 - 6.5 
Rankin et al. 2008 (40) Eggs, sausage, biscuit, pancake, jelly candy venipuncture S Y 53 900 17 8M/9F 26.5 ± 7.6 33.5 ± 6.7 4 ↔ - 5.5 ± 5.8 - 5.5 
Rosenkranz et al. 2010 [7] Ice cream, whipping cream venipuncture P N 45 982 - 2590 20 10M/10W 21.9 ± 1.9 24.4 ± 4.5 2 ↔ - 1.73 ± 1.67 - 5.5 
Schmid et al. 2015 (42) Bread, salami, palm fat, boiled eggs cannula P N 61 1005 21 21M/0W 41.8 ± 9.0 27.1 ± 8.2 6 ↔ - 1.2 ± 1.2 - 4.5 
Schwander et al. 2014 – NW (43) Bread, salami, palm fat, boiled eggs cannula P N 61 1000 19 19M/0W 40.6 ± 9.2 23.6 ± 1.4 6 ↔ - 0.6 ± 0.2 - 4.5 
Schwander et al. 2014 – obese (43) Bread, salami, palm fat, boiled eggs cannula P N 61 1000 17 17M/0W 44.1 ± 8.0 38.8 ± 4.9 6 ↔ - 2.4 ± 0.4 - 4.5 
Schwander et al. 2014 – NW (43) Bread, salami, palm fat, boiled eggs cannula P N 61 1500 19 19M/0W 40.6 ± 9.2 23.6 ± 1.4 6 ↓ 6 1.0 ± 0.3 0.8 ± 0.2 4.5 
Schwander et al. 2014 – obese (43) Bread, salami, palm fat, boiled eggs cannula P N 61 1500 17 17M/0W 44.1 ± 8.0 38.8 ± 4.9 6 ↔ - 3.5 ± 1.0 - 4.5 
Tholstrup et al. 2011 (46) Mashed potatoes with fat powder NS S Y 76 620 10 0M/10F 38.2 ± 10.7 20.9 ± 1.3 6 ↔ - 0.95 ± 0.24 - 5 
Wood et al. 2011 (49) Fast food burger, hash browns venipuncture P N 49 919 21 9M/12F 49.6 ± 4.6 24.0 ± 0.7 4 ↔ - 1.6 ± 1.0 - 4.5 
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Supplemental Table 1. Details of studies that assessed pre- and post-HFM CRP in healthy 
participants. 
Twenty-nine studies met the inclusion criteria and assessed CRP before and after consumption of 
a HFM. If studies separately assessed different groups or utilized different test meals (each had 
to meet established participant or meal criteria), those specific subsets are specified alongside the 
study. When applicable, data represent Mean ± SD or Mean (Range). Concentration values are in 
mg/mL. Arrows represent significant increase (↑), significant decrease (↓), or no significant 
change (↔) detected in response to the HFM. References in parentheses are originally cited in 
the main printed paper, while references in brackets are located only in the Supplemental 
References section. 
Abbreviations: BLOOD, method for drawing blood; BMI, body mass index; FASTING, 
baseline/fasting concentration of the marker; FAT, percentage of energy (%E) in the test meal 
from fat; M/F, ratio of males to females; MO, whether or not CRP was the main outcome being 
studied; N, sample size; NS, not stated; PEAK, peak or maximal observed concentration of the 
marker (“-“ if not applicable); PPP, length of postprandial period assessment in hours; S/P, 
serum or plasma; TTP, time to peak or maximal observed concentration if a significant change 
was detected (“-“ if not applicable). 
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ARTICLE (REF) MEAL BLOOD S/P MO FAT ENERGY N M/F AGE BMI PPP ↑↓↔ TTP FASTING PEAK QA 
     %E kcal   y kg/m2 hrs  hrs TNF, pg/mL TNF, pg/mL  
Bidwell et al. 2014 (15) Eggs, muffin, butter, sugary drink cannula P N 40 600 kcal 22 11M/11F 
M: 20.8 ± 0.7 
F: 21.5 ± 0.9 
M: 23.9 ± 0.9 
F: 21.1 ± 0.5 
6 ↑ NS NS NS 6 
Brandauer et al. 2013 (16) Sugar, heavy cream, chocolate syrup, powdered milk cannula P Y 84 1310 ± 34.1 10 10M/0F 27 ± 1 24.6 ± 0.7 4 ↔ - 5.2 ± 1.2 - 4.5 
Caixas et al. 2008 – lean (18) Liquid test meal cannula P Y 30 750 7 6M/1F 23.0 (21.0 - 26.0) 20.3 (18.9 - 25.1) 6 ↔ - 0.14 (0.05 - 0.19) - 4 
Caixas et al. 2008 – obese (18) Liquid test meal cannula P Y 30 750 7 6M/1F 26.0 (23.0 - 27.0) 43.9 (32.8 - 48.0) 6 ↔ - 0.13 (0.13 - 0.16) - 4 
Drew et al. 2014 (21) Turkey burger, white bread cannula P N 50 600 16 16M/0F 45 ± 11 27.6 ± 5.3 6 ↔ - 2.26 ± 0.64 - 3.5 
Esser et al. 2013 (23) Milk shake (cream, sugar, water) cannula P Y 85 954 20 20M/0F 22 ± 2 22.7 ± 2.4 6 ↔ - 6.12 ± 1.70 - 5 
Ghanim et al. 2009 (78) Egg, sausage, muffin, hash browns NS P N 42 910 10 5M/5F 32.4 ± 1.3 23.1 ± 0.6 3 ↔ - 2.09 ± 0.32 - 3 
Gill et al. 2003 (24) Whipping cream, fruit, cereal, nuts, chocolate cannula P N 67 1075 8 8M/0F 27.8 ± 12.1 23.6 ± 1.0 6 ↔ - 1.40 ± 0.52 - 5 
Jimenez-Gomez et al. 2009 (27) Butter, wholemeal bread, hard-boiled egg, whole milk venipuncture P Y 60 NS 20 20M/0F NS NS 9 ↔ -   - 6 
Johnson et al. 2016 (28) Ice cream, whipping cream cannula P N 45 1360 - 2160 12 12M/0F 23.0 ± 3.2 24.5 ± 2.7 4 ↔ - 6.48 ± 2.13 - 4 
Kiecolt-Glaser et al. 2015 (29) Eggs, turkey sausage, biscuits, gravy cannula S N 60 930 86 43M/43W 38.22 ± 8.18 32.07 ± 5.83 7 ↔ - 4.77 ± 1.12 - 4.5 
Kracmerova et al. 2014 (30) Pork meat, egg, French fries, hazelnut spread, croissant cannula P Y 47 1470 10 10M/0W 26.3 ± 1.04 23.11 ± 0.59 4 ↔ - 4.632 ± 0.410 - 3.5 
Mariotti et al. 2015 (33) Milk cream, sucrose, whey protein cannula P N 70 1200 10 10M/0F 34 ± 9 30.2 ± 1.5 6 ↔ - 5.44 ± 1.04 - 3.5 
Miglio et al. 2013 (34) Fried potatoes, eggs, cheese, bread rolls cannula P Y 52 1416 15 13M/2F 45 ± 8 26.7 ± 1.9 8 ↑ 8 29.1 ± 29.0 50.5 ± 32.3 4 
Nappo et al. 2002 (35) Sausage, bread, egg, butter, olive oil venipuncture P N 59 760 20 10M/10F 44 ± 5 26.8 ± 1.2 4 ↑ 2 2.9 ± 0.8 4.0 ± 0.8 5 
Payette et al. 2009 - Men (36) Cheese, eggs, toast, butter, cream, milk, peanut butter cannula P Y 64 1600 - 2200 39 39M/0F 44.0 ± 9.1 28.9 ± 4.3 8 ↓ 4 1.74 ± 0.48 1.57 ± 0.50 5 
Payette et al. 2009 - Women (36) Cheese, eggs, toast, butter, cream, milk, peanut butter cannula P Y 64 1600 - 2200 41 0M/41F 43.7 ± 9.4 26.5 ± 5.7 8 ↓ 4 1.91 ± 1.35 1.80 ± 1.29 5 
Peluso et al. 2012 (37) Fried potatoes, eggs, cheese, bread  cannula P N 55 1344 14 12M/2W 45.1 ± 8.6 26.8 ± 2.2 8 ↑ 8 31.3 ± 30.2 53.5 ± 16.9 2.5 
Phillips et al. 2013 – Lean (38) Bacon, egg, muffin, hash browns, milk cannula P N 52 989 10 10M/0W 43.4 ± 11.3 22.8 ± 1.5 6 ↔ - 0.6 ± 0.3 - 6 
Phillips et al. 2013 – Obese (38) Bacon, egg, muffin, hash browns, milk cannula P N 52 989 10 10M/0W 40.9 ± 9.8 38.2 ± 6.7 6 ↔ - 0.8 ± 0.4 - 6 
Poppitt et al. 2008 (39) Blueberry muffin cannula S Y 71 748 18 18M/0F 23 ± 4 22.9 ± 2.0 6 ↓ 1 736.1 ± 156.8 698.4 ± 164.5 6.5 
Sanders et al. 2011 (41) Muffin, milkshake cannula P N 53 846 50 25M/25W 
M: 25.4 ± 4.2 
W: 24.2 ± 6.3 
M: 23.3 ± 2.1 
W: 23.7 ± 3.4 
8 ↓ 4 1.5 ± 0.05 1.4 ± 0.05 5 
Schmid et al. 2015 (42) Bread, salami, palm fat, boiled eggs cannula P N 61 1005 21 21M/0W 41.8 ± 9.0 27.1 ± 8.2 6 ↔ - 3.6 ± 1.3 - 4.5 
Strohacker et al. 2012 (44) Sausage, egg, cheese, biscuit, hash browns cannula P N 59 1070 8 4M/4F 21 ± 3 23.1 ± 3.9 3 ↔ - 3.2 ± 1.4 - 5 
Teng et al. 2011 (45) Mashed potatoes, baked beans, milk, orange juice, lard NS S N 60 683 10 10M/0W 21.9 ± 0.7 21.0 ± 1.6 4 ↔ - 14.5 ± 2.0 - 5.5 
Twickler et al. 2003 (47) Liquid cream meal NS P Y 40 NS 10 6M/4F 48.6 ± 7.7 25.4 ± 1.6 24 ↑ 4 2.8 ± 0.8 4.7 ± 3.4 4 
Volek et al. 2008 (48) Whipping cream, pudding, macadamia nuts cannula P Y 84 908 30 16M/14W 30 ± 8 24.1 ± 4.3 6 ↔ - 1.06 ± 0.49 - 6 
Wood et al. 2011 (49) Fast food burger, hash browns venipuncture P N 49 919 21 9M/12F 49.6 ± 4.6 24.0 ± 0.7 4 ↔ - 1.4 ± 0.3 - 4.5 
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Supplemental Table 2. Details of studies that assessed pre- and post-HFM TNF-α in 
healthy participants. 
Twenty-eight studies met the inclusion criteria and assessed TNF-α before and after consumption 
of a HFM. If studies separately assessed different groups, those specific subsets are specified 
alongside the study. When applicable, data represent Mean ± SD or Mean (Range). 
Concentration values are in pg/mL. Arrows represent significant increase (↑), significant 
decrease (↓), or no significant change (↔) detected in response to the HFM. 
Abbreviations: BLOOD, method for drawing blood; BMI, body mass index; FASTING, 
baseline/fasting concentration of the marker; FAT, percentage of energy (%E) in the test meal 
from fat; M/F, ratio of males to females; MO, whether or not TNF-α was the main outcome 
being studied; N, sample size; NS, not stated; PEAK, peak or maximal observed concentration of 
the marker (“-“ if not applicable); PPP, length of postprandial period assessment in hours; S/P, 
serum or plasma; TTP, time to peak or maximal observed concentration if a significant change 
was detected (“-“ if not applicable). 
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ARTICLE (REF) MEAL BLOOD S/P MO FAT ENERGY N M:F AGE BMI PPP ↑↓↔ TTP FASTING PEAK QA 
     %E kcal   y kg/m2 hrs  hrs IL-8, pg/mL IL-8, pg/mL  
Brandauer et al. 2013 (16) Sugar, heavy cream, chocolate syrup, powdered milk cannula P Y 84 1310 ± 34.1 10 10M/0F 27 ± 1 24.6 ± 0.7 4 ↑ 4 2.33 ± 1.16 3.26 ± 2.56 4.5 
Esser et al. 2013 (23) Milk shake (cream, sugar, water) cannula P Y 85 954 20 20M/0F 22 ± 2 22.7 ± 2.4 6 ↔ - 4.08 ± 0.95 - 5 
Kracmerova et al. 2014 (30) Pork meat, egg, French fries, hazelnut spread, croissant cannula P Y 47 1470 10 10M/0W 26.3 ± 1.04 23.11 ± 0.59 4 ↔ - 1.95 ± 0.418 - 3.5 
Sanders et al. 2011 (41) Muffin, milkshake cannula P N 53 846 50 25M/25W 
M: 25.4 ± 4.2 
W: 24.2 ± 6.3 
M: 23.3 ± 2.1 
W: 23.7 ± 3.4 
8 ↔ - 0.8 ± 0.1 - 5 
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Supplemental Table 3. Details of studies that assessed pre- and post-HFM IL-8 in healthy 
participants. 
Four studies met the inclusion criteria and assessed IL-8 before and after consumption of a HFM. 
When applicable, data represent Mean ± SD. Concentration values are in pg/mL. Arrows 
represent significant increase (↑), significant decrease (↓), or no significant change (↔) detected 
in response to the HFM.  
Abbreviations: BLOOD, method for drawing blood; BMI, body mass index; FASTING, 
baseline/fasting concentration of the marker; FAT, percentage of energy (%E) in the test meal 
from fat; M/F, ratio of males to females; MO, whether or not IL-8 was the main outcome being 
studied; N, sample size; NS, not stated; PEAK, peak or maximal observed concentration of the 
marker (“-“ if not applicable); PPP, length of postprandial period assessment in hours; S/P, 
serum or plasma; TTP, time to peak or maximal observed concentration if a significant change 
was detected (“-“ if not applicable). 
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ARTICLE (REF) MEAL BLOOD S/P MO FAT ENERGY N M:F AGE BMI PPP ↑↓↔ TTP FASTING PEAK QA 
     %E kcal   y kg/m2 hrs  hrs IL-1, pg/mL IL-1, pg/mL  
Cheng et al. 2010 [8] Heavy whipping cream, milk powder, syrup cannula S Y 78 782/ sq m 838 456M/382W 44 ± 14 26.6 ± 4.4 6 ↔ - 0.8 (0.8 - 0.8) - 6 
Esser et al. 2013 (23) Milk shake (cream, sugar, water) cannula P Y 85 954 20 20M/0F 22 ± 2 22.7 ± 2.4 6 ↔ - 0.47 ± 0.31 - 5 
Teng et al. 2011 (45) Mashed potatoes, baked beans, milk, orange juice, lard NS S N 60 683 10 10M/0W 21.9 ± 0.7 21.0 ± 1.6 4 ↓ 4 6.1 ± 1.0 5.2 ± 1.0 5.5 
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Supplemental Table 4. Details of studies that assessed pre- and post-HFM IL-1β in healthy 
participants. 
Three studies met the inclusion criteria and assessed IL-1β before and after consumption of a 
HFM. When applicable, data represent Mean ± SD. Concentration values are in pg/mL. Arrows 
represent significant increase (↑), significant decrease (↓), or no significant change (↔) detected 
in response to the HFM. References in parentheses are originally cited in the main printed paper, 
while references in brackets are located only in the Supplemental References section. 
Abbreviations: BLOOD, method for drawing blood; BMI, body mass index; FASTING, 
baseline/fasting concentration of the marker; FAT, percentage of energy (%E) in the test meal 
from fat; M/F, ratio of males to females; MO, whether or not IL-1β was the main outcome being 
studied; N, sample size; NS, not stated; PEAK, peak or maximal observed concentration of the 
marker (“-“ if not applicable); PPP, length of postprandial period assessment in hours; S/P, 
serum or plasma; TTP, time to peak or maximal observed concentration if a significant change 
was detected (“-“ if not applicable). 
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